Summary:

All articles in House section

CHILDREN'S HEALTH ACT OF 2000
(House of Representatives - September 27, 2000)

Text of this article available as: TXT PDF [Pages H8206-H8265] CHILDREN'S HEALTH ACT OF 2000 Ms. PRYCE of Ohio. Mr. Speaker, by direction of the Committee on Rules, I call up House Resolution 594 and ask for its immediate consideration. The Clerk read the resolution, as follows: H. Res. 594 Resolved, That upon adoption of this resolution it shall be in order to take from the [[Page H8207]] Speaker's table the bill (H.R. 4365) to amend the Public Health Service Act with respect to children's health, with Senate amendment thereto, and to consider in the House, without intervention of any point of order, a motion offered by the chairman of the Committee on Commerce or his designee that the House concur in the Senate amendment. The Senate amendment and the motion shall be considered as read. The motion shall be debatable for one hour equally divided and controlled by the chairman and ranking minority member of the Committee on Commerce. The previous question shall be considered as ordered on the motion to final adoption without intervening motion. The SPEAKER pro tempore (Mr. Ose). The gentlewoman from Ohio (Ms. Pryce) is recognized for 1 hour. Ms. PRYCE of Ohio. Mr. Speaker, for the purpose of debate only, I yield the customary 30 minutes to the gentleman from Texas (Mr. Frost); pending which I yield myself such time as I may consume. During consideration of the resolution, all time yielded is for the purpose of debate only. Mr. Speaker, House Resolution 594 is a rule waiving all points of order against a motion to concur in the Senate amendment to H.R. 4365, the Children's Health Act of the year 2000. The rule provides 1 hour of debate on the motion to be equally divided and controlled by the chairman and ranking minority member of the Committee on Commerce. Mr. Speaker, H.R. 4365, the Children's Health Act of 2000, was passed in the House earlier this year on May 9 by a vote of 419 to two. Last week, our colleagues in the other body considered and passed this important legislation with an amendment by unanimous consent. Adoption of this rule and passage of this legislation today is the last step in our work to sending this bill to the President for his signature and thus making this important package a reality. I would like to congratulate the gentleman from Florida (Mr. Bilirakis) and the gentleman from Ohio (Mr. Brown) for their renewed efforts and success on this important legislation and also to commend the gentleman from Virginia (Mr. Bliley), chairman of the Committee on Commerce and the gentleman from Michigan (Mr. Dingell), ranking member, for their hard work and leadership. H.R. 4365, along with the decisions made by the other body, is a comprehensive package of several important children's health bills. Together it addresses a wide variety of critical issues, including day care safety, maternal and infant health, pediatric public health promotion, pediatric research, along with efforts to fight youth drug abuse and provide mental health services. {time} 1030 The legislation includes two important divisions. Division A addresses issues regarding children's health; while Division B focuses on youth drug abuse. Together this package will form the foundation for efforts to address the unique needs of one of our most important constituencies: Our children. The provisions contained in the second part of this legislation, Division D, include a number of provisions previously introduced and considered in the House of Representatives and will allow us to tackle the plague of drug abuse and addiction which are moving through many of our communities. The 1999 National Household Survey on drug abuse reported that some 10.9 percent of our youths, between the ages of 12 and 17, use some form of illicit drug. Just as tragic are the report's findings that alcohol use is also on the rise with our Nation's youth, with some 10.4 million drinkers under the legal age of 21. H.R. 4365 reauthorizes and improves the Substance Abuse and Mental Health Services Administration, SAMSHA, by giving it greater focus on our youth and increased flexibility and accountability for the States. It will provide the needed funds for community-based programs, helping individuals with substance abuse and mental health disorders. It includes the Drug Addiction Treatment Act, introduced by the gentleman from Virginia (Mr. Bliley), to permit qualified physicians to treat their addicted patients and speed up the drug approval process of narcotic drugs needed for additional treatment. Finally, H.R. 4365 includes important provisions to reduce the proliferation of the drug methamphetamine, and tackle the devastating drug currently on the rise with our youth commonly known as Ecstasy. Mr. Speaker, we all hope that the wealth of our Nation and the amazing technological advances that have been made in medicine will give us the necessary resources to protect our children from harm. We have made tremendous progress, but the sad fact is that there are still so many diseases that affect our children for which there is no cure or even an effective treatment. Division A of the legislation before us will give child victims and their families hope by devoting more Federal resources to diseases such as autism, asthma, juvenile diabetes and arthritis. I am especially pleased that this new version of H.R. 4365 includes specific provisions on childhood cancer. By awarding grants, expanding data collection, encouraging uniform reporting standards and urging the national coordination of activities, this bill will go a long way in the battle against this disease that takes the lives of so many of our Nation's children. This legislation also focuses on a new pediatric research initiative at NIH, and reauthorizes money to train physicians at children's hospitals, in order to help us better understand the way in which diseases attack children and how to give them the most effective and appropriate care. There are critical differences between medical care for adults and medical care for children that must be reflected in the training of physicians and treatments designed for a child's system, which is still developing. The children's hospitals across the Nation need funding to adequately train their physicians, and I am so very pleased that H.R. 4365 extends the authorization of appropriations for graduate medical education programs in children's hospitals through fiscal year 2005. This is an issue of fairness, and full authorization is necessary to provide children's hospitals support that is on par with that received by teaching hospitals that care for adults. This legislation recognizes and focuses on these many important differences. Mr. Speaker, while we may never be able to make a child understand why he or she is sick or is made to suffer, we can invest in the research that will allow our best and brightest scientists to solve the mysteries of childhood disease so that more children can have the carefree youths to which they are entitled. What better way to invest our Nation's resources? Mr. Speaker, this measure is straightforward and noncontroversial and its adoption will allow us to complete the work and the business of the House and pass this comprehensive package. I urge all my colleagues to support both the rule and this very important child health initiative. Mr. Speaker, I reserve the balance of my time. Mr. FROST. Mr. Speaker, I yield myself such time as I may consume. As the gentlewoman has explained, this rule will take a Senate amendment from the Speaker's desk and agree to it. Under this procedure, there will be no opportunity to change the bill under consideration with a motion to recommit. Mr. Speaker, 6 years after the Republican majority took control of this House, the Republican leadership has yet to find a way to effectively manage the business of the House. It is 3 days before the end of the fiscal year and 9 days before the Congress is scheduled to end, yet only 2 of the 13 appropriation bills have been sent to the President to be signed; we have yet to consider on this floor the funding bills we need to help people find housing or have safe transportation to get to work or plow their ground to produce food or learn the basic skills to be able to get and hold a job in the modern day workplace. Last night, the members of the Committee on Rules were held hostage for hours past the last vote so that we might be available to bail out the Republican leadership so that the House might have some business to conduct today. Why should the Committee on Rules be held here until 9:30? For one very simple reason, Mr. Speaker. And that is because the majority party still has not figured out how to run this institution in an efficient manner and [[Page H8208]] could not find anything to do on the floor today. However, sometime around 9 p.m. the Republican leadership came up with a solution. So what did they do? The Republican leadership has taken one of the bills that was supposed to be considered yesterday under procedures for noncontroversial bills, suspension of the rules, and moved it to today to be considered under a rule. I do not mean to take anything away from the value of this bill. The Children's Health Act is vitally important to help find new ways to prevent or cure diseases which affect our children. But it should have been passed last night under suspension of the rules, as it was intended to be done. The health organizations, including the March of Dimes, the Spina Bifida Foundation, the Autism Society of America, the Association of Maternal and Child Health Programs, the Epilepsy Foundation, the Cereberal Palsy Association, and many, many others have worked hard to see the bill to completion and were counting on us to do our work. It is past time to get on with this business. Mr. Speaker, I strongly support the Children's Health Act of 2000. This bill now spans 400 pages and has two basic purposes. The first addresses a host of specific childhood health problems and prenatal risk factors, including many provisions which passed in the House earlier this year. The bill authorizes research and public health and health education services that respond to fragile X syndrome, epilepsy, asthma, childhood lead poisoning, pediatric cancers, childhood obesity prevention, traumatic brain injury, juvenile diabetes, hearing loss, oral health, autism, arthritis, muscular dystrophy, autoimmune conditions, child care safety and pediatric organ transplants. It also provides block grants to the States for laboratory infrastructure and patient care services for those affected with or at risk for genetic conditions. The bill contains the first ever authorization of the very successful Healthy Start demonstration project, now in their ninth year of reducing infant mortality and improving pregnancy outcomes in underserved populations. The second feature of this bill covers a wide range of youth drug and mental health service programs that will strengthen America's communities, including extending and reauthorizing programs administered by the Substance Abuse and Mental Health Services Administration. These programs provide critical safety net services for individuals and families with substance abuse problems and mental illness, and also exclusively target youth. It also supports public and professional education programs related to substance abuse and mental illness. The breadth of services provided here range from an underage drinking provision and a suicide prevention initiative, to services for youth offenders, the homeless, and adults with fetal alcohol syndrome. This large and complex bill, however, is marked with a number of procedural irregularities. As worthy as the goals may be, no bill of this scope and magnitude should proceed to the floor without going through the committee process, yet this occurred in the majority's apparent rush to move this bill to the floor. For example, the bill contains a provision that invokes charitable choice. This is a difficult issue for many Members, yet the Committee on the Judiciary was never given the opportunity for public debate on this issue. I know this is of particular concern to my colleague, the gentleman from Virginia (Mr. Scott), who is here to voice his concerns this morning. The second example is marked with some irony. The fine provision promoting safe motherhood includes a public education initiative addressing the dangers of alcohol, tobacco and illicit drug use in pregnancy. Most women do not begin smoking during pregnancy, they begin as adolescents. Yet neither the House nor the Committee on Commerce had the opportunity to even debate the issue of FDA regulation of youth tobacco use during this Congress. I will vote for this bill, however, I want America's children to know that while H.R. 4365 is a measurable step toward improving the quality of their collective health, we can and should do better. It is obvious that this Congress will fail to address many major health care issues that confront us. I am only grateful we have the opportunity to vote for this bill and do something constructive to improve the health care of our Nation's children. Mr. Speaker, I yield 3 minutes to the gentleman from Virginia (Mr. Scott). Mr. SCOTT. Mr. Speaker, I thank the gentleman for yielding me this time, and I rise to oppose the rule because, in its present form, good health care for children now includes a bad crime bill and a provision which waters down our fundamental civil rights. A good child health care bill should not come at such a price. By adopting the rule, we will prohibit amendments to the bill that could fix the methamphetamine drug part of the bill. A similar bill was considered in the Committee on the Judiciary, and amendments could have conformed that 46-page bill to the formal deliberations of the committee. But the rule prohibits amendments, and so the bill now provides new Draconian mandatory minimums for violations of methamphetamines, mandatory minimums that everyone knows do not work. The same mandatory minimums as for crack cocaine. Now, it is interesting that crack cocaine is prevalent in the black community; methamphetamine is more prevalent in the Hispanic community. They get the Draconian mandatory minimums. However, there is an exception to all of this. Ecstasy, which is prevalent in the middle class white community, does not suffer the same mandatory minimums. The Committee on the Judiciary at least had the common decency to make them all equal. But now we have a rule which prohibits any consideration for equalizing this penalty. We have this exemption and, because of the rule, we have to just do it. The rule also protects another form of discrimination: Religious discrimination. Section 3305 has a provision that allows some sponsors of federally funded programs to discriminate on employment based on religion. That is they can tell otherwise qualified individuals that they do not hire their kind because of their religion. These are federally funded programs. We cannot address this discrimination because the rule protects that provision and does not allow any amendments. So if we want good child health care, we have to accept the discrimination; we have to accept the mandatory minimums, with the exception for the middle class white kids. We should not be forced to accept ineffective counterproductive mandatory minimums and religious discrimination as a price for good child health care, and that is why I oppose this rule. Mr. FROST. Mr. Speaker, I yield 2 minutes to the gentleman from New Jersey (Mr. Pascrell). (Mr. PASCRELL asked and was given permission to revise and extend his remarks.) Mr. PASCRELL. Mr. Speaker, I thank the gentleman from Texas for yielding me this time. Mr. Speaker, I am thrilled that the Children's Health Act of 2000 is on the floor today. I would like to thank the Chair of the Subcommittee on Health and the Environment, the gentleman from Florida (Mr. Bilirakis), and the ranking member, the gentleman from Ohio (Mr. Brown), for their leadership and determination to see the bill through. But I want to take special time to salute the gentleman from Pennsylvania (Mr. Greenwood) for his work on behalf of children in America. The gentleman from Pennsylvania has worked tirelessly on behalf of millions of Americans suffering from traumatic brain injury. He has also assisted in my efforts to create the first national traumatic brain injury registry, which is critical. I first became involved with this issue several years ago when a constituent of mine, Dennis Benigno, approached me to tell me about his son, who was struck by a car, hospitalized for months, leaving him with severe cognitive and physical damage. {time} 1045 As a result of his son's accident, Mr. Benigno has been on the front lines researching the disease, informing others, reaching out to the medical research and scientific community, and lobbying elected officials like myself. I am proud of the efforts and the progress my good friend has made on [[Page H8209]] behalf of traumatic brain injury, and I am pleased that the national registry will be included in the Children's Health Act. These brain injury registries will also charge hospitals and local and State departments of health with the task of collecting data for up to a year following the injury. A national registry will help all of us to better understand the injury, what types of treatment people have received, what services they use, and how we can best link people with services. I also hope that we fight each day, like Dennis does, to raise awareness of this disease and to fight for the injured, like his son. I urge all my colleagues to, when the bill comes up after we debate the rule, vote for the passage of this bill. Ms. PRYCE of Ohio. Mr. Speaker, I reserve the balance of my time. Mr. FROST. Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, as I indicated in my opening remarks, this is a good bill. The gentleman from Virginia (Mr. Scott) has some legitimate concerns about a particular matter that he was not able to address. The overall bill is an important piece of legislation. We have concerns on this side that we seem to be treading water here in not being able to bring anything up on the floor on a regular basis. We do not know from day to day what is going to be considered. This bill could have been done on suspension yesterday. That does not diminish the bill. This is an important piece of legislation. I support the bill and support the rule. Mr. Speaker, I yield back the balance of my time. Ms. PRYCE of Ohio. Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, in closing, let me just respond. This very well could have been considered under the suspension calendar last night. We would all have been considering this bill at about 11 p.m. if that were the case. Instead, we chose to come back in the light of day and with everyone well rested and alert and consider this important piece of legislation and allow the American public to hear all the goods things that we are promoting and adopting. In closing, let me remind my colleagues that the House has already passed this with a strong bipartisan support vote of 419-2. Our work today will allow us to dedicate important resources and focus Members on the very unique needs in the health and well-being of our children. I urge adoption of this straightforward, noncontroversial rule and passage of the comprehensive legislation. I applaud my colleagues, the gentleman from Florida (Chairman Bilirakis), and my colleague, the gentleman from Ohio (Mr. Brown), on their hard work. Mr. Speaker, I yield back the balance of my time, and I move the previous question on the resolution. The previous question was ordered. The resolution was agreed to. A motion to reconsider was laid on the table. Mr. BILIRAKIS. Mr. Speaker, pursuant to House Resolution 594, I call up from the Speaker's table the bill (H.R. 4365) to amend the Public Health Service Act with respect to children's health, with the Senate amendment thereto, and ask for its immediate consideration. The Clerk read the title of the bill. Motion Offered by Mr. Bilirakis Mr. BILIRAKIS. Mr. Speaker, I offer a motion. The SPEAKER pro tempore (Mr. Ose). The Clerk will designate the motion. The text of the motion is as follows: Mr. Bilirakis moves that the House concur in the Senate amendment to H.R. 4365, as follows: Senate amendment: Strike out all after the enacting clause and insert: SECTION 1. SHORT TITLE. This Act may be cited as the ``Children's Health Act of 2000''. SEC. 2. TABLE OF CONTENTS. The table of contents for this Act is as follows: Sec. 1. Short title. Sec. 2. Table of contents. DIVISION A--CHILDREN'S HEALTH TITLE I--AUTISM Sec. 101. Expansion, intensification, and coordination of activities of National Institutes of Health with respect to research on autism. Sec. 102. Developmental disabilities surveillance and research programs. Sec. 103. Information and education. Sec. 104. Inter-agency Autism Coordinating Committee. Sec. 105. Report to Congress. TITLE II--RESEARCH AND DEVELOPMENT REGARDING FRAGILE X Sec. 201. National Institute of Child Health and Human Development; research on fragile X. TITLE III--JUVENILE ARTHRITIS AND RELATED CONDITIONS Sec. 301. National Institute of Arthritis and Musculoskeletal and Skin Diseases; research on juvenile arthritis and related conditions. Sec. 302. Information clearinghouse. TITLE IV--REDUCING BURDEN OF DIABETES AMONG CHILDREN AND YOUTH Sec. 401. Programs of Centers for Disease Control and Prevention. Sec. 402. Programs of National Institutes of Health. TITLE V--ASTHMA SERVICES FOR CHILDREN Subtitle A--Asthma Services Sec. 501. Grants for children's asthma relief. Sec. 502. Technical and conforming amendments. Subtitle B--Prevention Activities Sec. 511. Preventive health and health services block grant; systems for reducing asthma-related illnesses through integrated pest management. Subtitle C--Coordination of Federal Activities Sec. 521. Coordination through National Institutes of Health. Subtitle D--Compilation of Data Sec. 531. Compilation of data by Centers for Disease Control and Prevention. TITLE VI--BIRTH DEFECTS PREVENTION ACTIVITIES Subtitle A--Folic Acid Promotion Sec. 601. Program regarding effects of folic acid in prevention of birth defects. Subtitle B--National Center on Birth Defects and Developmental Disabilities Sec. 611. National Center on Birth Defects and Developmental Disabilities. TITLE VII--EARLY DETECTION, DIAGNOSIS, AND TREATMENT REGARDING HEARING LOSS IN INFANTS Sec. 701. Purposes. Sec. 702. Programs of Health Resources and Services Administration, Centers for Disease Control and Prevention, and National Institutes of Health. TITLE VIII--CHILDREN AND EPILEPSY Sec. 801. National public health campaign on epilepsy; seizure disorder demonstration projects in medically underserved areas. TITLE IX--SAFE MOTHERHOOD; INFANT HEALTH PROMOTION Subtitle A--Safe Motherhood Prevention Research Sec. 901. Prevention research and other activities. Subtitle B--Pregnant Women and Infants Health Promotion Sec. 911. Programs regarding prenatal and postnatal health. TITLE X--PEDIATRIC RESEARCH INITIATIVE Sec. 1001. Establishment of pediatric research initiative. Sec. 1002. Investment in tomorrow's pediatric researchers. Sec. 1003. Review of regulations. Sec. 1004. Long-term child development study. TITLE XI--CHILDHOOD MALIGNANCIES Sec. 1101. Programs of Centers for Disease Control and Prevention and National Institutes of Health. TITLE XII--ADOPTION AWARENESS Subtitle A--Infant Adoption Awareness Sec. 1201. Grants regarding infant adoption awareness. Subtitle B--Special Needs Adoption Awareness Sec. 1211. Special needs adoption programs; public awareness campaign and other activities. TITLE XIII--TRAUMATIC BRAIN INJURY Sec. 1301. Programs of Centers for Disease Control and Prevention. Sec. 1302. Study and monitor incidence and prevalence. Sec. 1303. Programs of National Institutes of Health. Sec. 1304. Programs of Health Resources and Services Administration. Sec. 1305. State grants for protection and advocacy services. Sec. 1306. Authorization of appropriations for certain programs. TITLE XIV--CHILD CARE SAFETY AND HEALTH GRANTS Sec. 1401. Definitions. Sec. 1402. Authorization of appropriations. Sec. 1403. Programs. Sec. 1404. Amounts reserved; allotments. Sec. 1405. State applications. Sec. 1406. Use of funds. Sec. 1407. Reports. TITLE XV--HEALTHY START INITIATIVE Sec. 1501. Continuation of healthy start program. [[Page H8210]] TITLE XVI--ORAL HEALTH PROMOTION AND DISEASE PREVENTION Sec. 1601. Identification of interventions that reduce the burden and transmission of oral, dental, and craniofacial diseases in high risk populations; development of approaches for pediatric oral and craniofacial assessment. Sec. 1602. Oral health promotion and disease prevention. Sec. 1603. Coordinated program to improve pediatric oral health. TITLE XVII--VACCINE-RELATED PROGRAMS Subtitle A--Vaccine Compensation Program Sec. 1701. Content of petitions. Subtitle B-- Childhood Immunizations Sec. 1711. Childhood immunizations. TITLE XVIII--HEPATITIS C Sec. 1801. Surveillance and education regarding hepatitis C. TITLE XIX--NIH INITIATIVE ON AUTOIMMUNE DISEASES Sec. 1901. Autoimmune diseases; initiative through Director of National Institutes of Health. TITLE XX--GRADUATE MEDICAL EDUCATION PROGRAMS IN CHILDREN'S HOSPITALS Sec. 2001. Provisions to revise and extend program. TITLE XXI--SPECIAL NEEDS OF CHILDREN REGARDING ORGAN TRANSPLANTATION Sec. 2101. Organ Procurement and Transplantation Network; amendments regarding needs of children. TITLE XXII--MUSCULAR DYSTROPHY RESEARCH Sec. 2201. Muscular dystrophy research. TITLE XXIII--CHILDREN AND TOURETTE SYNDROME AWARENESS Sec. 2301. Grants regarding Tourette Syndrome. TITLE XXIV--CHILDHOOD OBESITY PREVENTION Sec. 2401. Programs operated through the Centers for Disease Control and Prevention. TITLE XXV--EARLY DETECTION AND TREATMENT REGARDING CHILDHOOD LEAD POISONING Sec. 2501. Centers for Disease Control and Prevention efforts to combat childhood lead poisoning. Sec. 2502. Grants for lead poisoning related activities. Sec. 2503. Training and reports by the Health Resources and Services Administration. Sec. 2504. Screenings, referrals, and education regarding lead poisoning. TITLE XXVI--SCREENING FOR HERITABLE DISORDERS Sec. 2601. Program to improve the ability of States to provide newborn and child screening for heritable disorders. TITLE XXVII--PEDIATRIC RESEARCH PROTECTIONS Sec. 2701. Requirement for additional protections for children involved in research. TITLE XXVIII--MISCELLANEOUS PROVISIONS Sec. 2801. Report regarding research on rare diseases in children. Sec. 2802. Study on metabolic disorders. TITLE XXIX--EFFECTIVE DATE Sec. 2901. Effective date. DIVISION B--YOUTH DRUG AND MENTAL HEALTH SERVICES Sec. 3001. Short title. TITLE XXXI--PROVISIONS RELATING TO SERVICES FOR CHILDREN AND ADOLESCENTS Sec. 3101. Children and violence. Sec. 3102. Emergency response. Sec. 3103. High risk youth reauthorization. Sec. 3104. Substance abuse treatment services for children and adolescents. Sec. 3105. Comprehensive community services for children with serious emotional disturbance. Sec. 3106. Services for children of substance abusers. Sec. 3107. Services for youth offenders. Sec. 3108. Grants for strengthening families through community partnerships. Sec. 3109. Programs to reduce underage drinking. Sec. 3110. Services for individuals with fetal alcohol syndrome. Sec. 3111. Suicide prevention. Sec. 3112. General provisions. TITLE XXXII--PROVISIONS RELATING TO MENTAL HEALTH Sec. 3201. Priority mental health needs of regional and national significance. Sec. 3202. Grants for the benefit of homeless individuals. Sec. 3203. Projects for assistance in transition from homelessness. Sec. 3204. Community mental health services performance partnership block grant. Sec. 3205. Determination of allotment. Sec. 3206. Protection and Advocacy for Mentally Ill Individuals Act of 1986. Sec. 3207. Requirement relating to the rights of residents of certain facilities. Sec. 3208. Requirement relating to the rights of residents of certain non-medical, community-based facilities for children and youth. Sec. 3209. Emergency mental health centers. Sec. 3210. Grants for jail diversion programs. Sec. 3211. Improving outcomes for children and adolescents through services integration between child welfare and mental health services. Sec. 3212. Grants for the integrated treatment of serious mental illness and co-occurring substance abuse. Sec. 3213. Training grants. TITLE XXXIII--PROVISIONS RELATING TO SUBSTANCE ABUSE Sec. 3301. Priority substance abuse treatment needs of regional and national significance. Sec. 3302. Priority substance abuse prevention needs of regional and national significance. Sec. 3303. Substance abuse prevention and treatment performance partnership block grant. Sec. 3304. Determination of allotments. Sec. 3305. Nondiscrimination and institutional safeguards for religious providers. Sec. 3306. Alcohol and drug prevention or treatment services for Indians and Native Alaskans. Sec. 3307. Establishment of commission. TITLE XXXIV--PROVISIONS RELATING TO FLEXIBILITY AND ACCOUNTABILITY Sec. 3401. General authorities and peer review. Sec. 3402. Advisory councils. Sec. 3403. General provisions for the performance partnership block grants. Sec. 3404. Data infrastructure projects. Sec. 3405. Repeal of obsolete addict referral provisions. Sec. 3406. Individuals with co-occurring disorders. Sec. 3407. Services for individuals with co-occurring disorders. TITLE XXXV--WAIVER AUTHORITY FOR PHYSICIANS WHO DISPENSE OR PRESCRIBE CERTAIN NARCOTIC DRUGS FOR MAINTENANCE TREATMENT OR DETOXIFICATION TREATMENT Sec. 3501. Short title. Sec. 3502. Amendment to Controlled Substances Act. TITLE XXXVI--METHAMPHETAMINE AND OTHER CONTROLLED SUBSTANCES Sec. 3601. Short title. Subtitle A--Methamphetamine Production, Trafficking, and Abuse Part I--Criminal Penalties Sec. 3611. Enhanced punishment of amphetamine laboratory operators. Sec. 3612. Enhanced punishment of amphetamine or methamphetamine laboratory operators. Sec. 3613. Mandatory restitution for violations of Controlled Substances Act and Controlled Substances Import and Export Act relating to amphetamine and methamphetamine. Sec. 3614. Methamphetamine paraphernalia. Part II--Enhanced Law Enforcement Sec. 3621. Environmental hazards associated with illegal manufacture of amphetamine and methamphetamine. Sec. 3622. Reduction in retail sales transaction threshold for non-safe harbor products containing pseudoephedrine or phenylpropanolamine. Sec. 3623. Training for Drug Enforcement Administration and State and local law enforcement personnel relating to clandestine laboratories. Sec. 3624. Combating methamphetamine and amphetamine in high intensity drug trafficking areas. Sec. 3625. Combating amphetamine and methamphetamine manufacturing and trafficking. Part III--Abuse Prevention and Treatment Sec. 3631. Expansion of methamphetamine research. Sec. 3632. Methamphetamine and amphetamine treatment initiative by Center for Substance Abuse Treatment. Sec. 3633. Study of methamphetamine treatment. Part IV--Reports Sec. 3641. Reports on consumption of methamphetamine and other illicit drugs in rural areas, metropolitan areas, and consolidated metropolitan areas. Sec. 3642. Report on diversion of ordinary, over-the-counter pseudoephedrine and phenylpropanolamine products. Subtitle B--Controlled Substances Generally Sec. 3651. Enhanced punishment for trafficking in list I chemicals. Sec. 3652. Mail order requirements. Sec. 3653. Theft and transportation of anhydrous ammonia for purposes of illicit production of controlled substances. Subtitle C--Ecstasy Anti-Proliferation Act of 2000 Sec. 3661. Short title. Sec. 3662. Findings. Sec. 3663. Enhanced punishment of Ecstasy traffickers. Sec. 3664. Emergency authority to United States Sentencing Commission. Sec. 3665. Expansion of Ecstasy and club drugs abuse prevention efforts. Subtitle D--Miscellaneous Sec. 3671. Antidrug messages on Federal Government Internet websites. Sec. 3672. Reimbursement by Drug Enforcement Administration of expenses incurred to remediate methamphetamine laboratories. Sec. 3673. Severability. [[Page H8211]] DIVISION A--CHILDREN'S HEALTH TITLE I--AUTISM SEC. 101. EXPANSION, INTENSIFICATION, AND COORDINATION OF ACTIVITIES OF NATIONAL INSTITUTES OF HEALTH WITH RESPECT TO RESEARCH ON AUTISM. Part B of title IV of the Public Health Service Act (42 U.S.C. 284 et seq.) is amended by adding at the end the following section: ``expansion, intensification, and coordination of activities of national institutes of health with respect to research on autism ``Sec. 409C. (a) In General.-- ``(1) Expansion of activities.--The Director of NIH (in this section referred to as the `Director') shall expand, intensify, and coordinate the activities of the National Institutes of Health with respect to research on autism. ``(2) Administration of program; collaboration among agencies.--The Director shall carry out this section acting through the Director of the National Institute of Mental Health and in collaboration with any other agencies that the Director determines appropriate. ``(b) Centers of Excellence.-- ``(1) In general.--The Director shall under subsection (a)(1) make awards of grants and contracts to public or nonprofit private entities to pay all or part of the cost of planning, establishing, improving, and providing basic operating support for centers of excellence regarding research on autism. ``(2) Research.--Each center under paragraph (1) shall conduct basic and clinical research into autism. Such research should include investigations into the cause, diagnosis, early detection, prevention, control, and treatment of autism. The centers, as a group, shall conduct research including the fields of developmental neurobiology, genetics, and psychopharmacology. ``(3) Services for patients.-- ``(A) In general.--A center under paragraph (1) may expend amounts provided under such paragraph to carry out a program to make individuals aware of opportunities to participate as subjects in research conducted by the centers. ``(B) Referrals and costs.--A program under subparagraph (A) may, in accordance with such criteria as the Director may establish, provide to the subjects described in such subparagraph, referrals for health and other services, and such patient care costs as are required for research. ``(C) Availability and access.--The extent to which a center can demonstrate availability and access to clinical services shall be considered by the Director in decisions about awarding grants to applicants which meet the scientific criteria for funding under this section. ``(4) Coordination of centers; reports.--The Director shall, as appropriate, provide for the coordination of information among centers under paragraph (1) and ensure regular communication between such centers, and may require the periodic preparation of reports on the activities of the centers and the submission of the reports to the Director. ``(5) Organization of centers.--Each center under paragraph (1) shall use the facilities of a single institution, or be formed from a consortium of cooperating institutions, meeting such requirements as may be prescribed by the Director. ``(6) Number of centers; duration of support.-- ``(A) In general.--The Director shall provide for the establishment of not less than 5 centers under paragraph (1). ``(B) Duration.--Support for a center established under paragraph (1) may be provided under this section for a period of not to exceed 5 years. Such period may be extended for 1 or more additional periods not exceeding 5 years if the operations of such center have been reviewed by an appropriate technical and scientific peer review group established by the Director and if such group has recommended to the Director that such period should be extended. ``(c) Facilitation of Research.--The Director shall under subsection (a)(1) provide for a program under which samples of tissues and genetic materials that are of use in research on autism are donated, collected, preserved, and made available for such research. The program shall be carried out in accordance with accepted scientific and medical standards for the donation, collection, and preservation of such samples. ``(d) Public Input.--The Director shall under subsection (a)(1) provide for means through which the public can obtain information on the existing and planned programs and activities of the National Institutes of Health with respect to autism and through which the Director can receive comments from the public regarding such programs and activities. ``(e) Funding.--There are authorized to be appropriated such sums as may be necessary to carry out this section. Amounts appropriated under this subsection are in addition to any other amounts appropriated for such purpose.''. SEC. 102. DEVELOPMENTAL DISABILITIES SURVEILLANCE AND RESEARCH PROGRAMS. (a) National Autism and Pervasive Developmental Disabilities Surveillance Program.-- (1) In general.--The Secretary of Health and Human Services (in this section referred to as the ``Secretary''), acting through the Director of the Centers for Disease Control and Prevention, may make awards of grants and cooperative agreements for the collection, analysis, and reporting of data on autism and pervasive developmental disabilities. In making such awards, the Secretary may provide direct technical assistance in lieu of cash. (2) Eligibility.--To be eligible to receive an award under paragraph (1) an entity shall be a public or nonprofit private entity (including health departments of States and political subdivisions of States, and including universities and other educational entities). (b) Centers of Excellence in Autism and Pervasive Developmental Disabilities Epidemiology.-- (1) In general.--The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall establish not less than 3 regional centers of excellence in autism and pervasive developmental disabilities epidemiology for the purpose of collecting and analyzing information on the number, incidence, correlates, and causes of autism and related developmental disabilities. (2) Recipients of awards for establishment of centers.-- Centers under paragraph (1) shall be established and operated through the awarding of grants or cooperative agreements to public or nonprofit private entities that conduct research, including health departments of States and political subdivisions of States, and including universities and other educational entities. (3) Certain requirements.--An award for a center under paragraph (1) may be made only if the entity involved submits to the Secretary an application containing such agreements and information as the Secretary may require, including an agreement that the center involved will operate in accordance with the following: (A) The center will collect, analyze, and report autism and pervasive developmental disabilities data according to guidelines prescribed by the Director, after consultation with relevant State and local public health officials, private sector developmental disability researchers, and advocates for those with developmental disabilities. (B) The center will assist with the development and coordination of State autism and pervasive developmental disabilities surveillance efforts within a region. (C) The center will identify eligible cases and controls through its surveillance systems and conduct research into factors which may cause autism and related developmental disabilities. (D) The center will develop or extend an area of special research expertise (including genetics, environmental exposure to contaminants, immunology, and other relevant research specialty areas). (c) Clearinghouse.--The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall carry out the following: (1) The Secretary shall establish a clearinghouse within the Centers for Disease Control and Prevention for the collection and storage of data generated from the monitoring programs established by this title. Through the clearinghouse, such Centers shall serve as the coordinating agency for autism and pervasive developmental disabilities surveillance activities. The functions of such a clearinghouse shall include facilitating the coordination of research and policy development relating to the epidemiology of autism and other pervasive developmental disabilities. (2) The Secretary shall coordinate the Federal response to requests for assistance from State health department officials regarding potential or alleged autism or developmental disability clusters. (d) Definition.--In this title, the term ``State'' means each of the several States, the District of Columbia, the Commonwealth of Puerto Rico, American Samoa, Guam, the Commonwealth of the Northern Mariana Islands, the Virgin Islands, and the Trust Territory of the Pacific Islands. (e) Authorization of Appropriations.--There are authorized to be appropriated such sums as may be necessary to carry out this section. SEC. 103. INFORMATION AND EDUCATION. (a) In General.--The Secretary shall establish and implement a program to provide information and education on autism to health professionals and the general public, including information and education on advances in the diagnosis and treatment of autism and training and continuing education through programs for scientists, physicians, and other health professionals who provide care for patients with autism. (b) Stipends.--The Secretary may use amounts made available under this section to provide stipends for health professionals who are enrolled in training programs under this section. (c) Authorization of Appropriations.--There are authorized to be appropriated such sums as may be necessary to carry out this section. SEC. 104. INTER-AGENCY AUTISM COORDINATING COMMITTEE. (a) Establishment.--The Secretary shall establish a committee to be known as the ``Autism Coordinating Committee'' (in this section referred to as the ``Committee'') to coordinate all efforts within the Department of Health and Human Services concerning autism, including activities carried out through the National Institutes of Health and the Centers for Disease Control and Prevention under this title (and the amendment made by this title). (b) Membership.-- (1) In general.--The Committee shall be composed of the Directors of such national research institutes, of the Centers for Disease Control and Prevention, and of such other agencies and such other officials as the Secretary determines appropriate. (2) Additional members.--If determined appropriate by the Secretary, the Secretary may appoint to the Committee-- (A) parents or legal guardians of individuals with autism or other pervasive developmental disorders; and [[Page H8212]] (B) representatives of other governmental agencies that serve children with autism such as the Department of Education. (c) Administrative Support; Terms of Service; Other Provisions.--The following shall apply with respect to the Committee: (1) The Committee shall receive necessary and appropriate administrative support from the Department of Health and Human Services. (2) Members of the Committee appointed under subsection (b)(2)(A) shall serve for a term of 3 years, and may serve for an unlimited number of terms if reappointed. (3) The Committee shall meet not less than 2 times each year. SEC. 105. REPORT TO CONGRESS. Not later than January 1, 2001, and each January 1 thereafter, the Secretary shall prepare and submit to the appropriate committees of Congress, a report concerning the implementation of this title and the amendments made by this title. TITLE II--RESEARCH AND DEVELOPMENT REGARDING FRAGILE X SEC. 201. NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT; RESEARCH ON FRAGILE X. Subpart 7 of part C of title IV of the Public Health Service Act is amended by adding at the end the following section: ``fragile x ``Sec. 452E. (a) Expansion and Coordination of Research Activities.--The Director of the Institute, after consultation with the advisory council for the Institute, shall expand, intensify, and coordinate the activities of the Institute with respect to research on the disease known as fragile X. ``(b) Research Centers.-- ``(1) In general.--The Director of the Institute shall make grants or enter into contracts for the development and operation of centers to conduct research for the purposes of improving the diagnosis and treatment of, and finding the cure for, fragile X. ``(2) Number of centers.-- ``(A) In general.--In carrying out paragraph (1), the Director of the Institute shall, to the extent that amounts are appropriated, and subject to subparagraph (B), provide for the establishment of at least three fragile X research centers. ``(B) Peer review requirement.--The Director of the Institute shall make a grant to, or enter into a contract with, an entity for purposes of establishing a center under paragraph (1) only if the grant or contract has been recommended after technical and scientific peer review required by regulations under section 492. ``(3) Activities.--The Director of the Institute, with the assistance of centers established under paragraph (1), shall conduct and support basic and biomedical research into the detection and treatment of fragile X. ``(4) Coordination among centers.--The Director of the Institute shall, as appropriate, provide for the coordination of the activities of the centers assisted under this section, including providing for the exchange of information among the centers. ``(5) Certain administrative requirements.--Each center assisted under paragraph (1) shall use the facilities of a single institution, or be formed from a consortium of cooperating institutions, meeting such requirements as may be prescribed by the Director of the Institute. ``(6) Duration of support.--Support may be provided to a center under paragraph (1) for a period not exceeding 5 years. Such period may be extended for one or more additional periods, each of which may not exceed 5 years, if the operations of such center have been reviewed by an appropriate technical and scientific peer review group established by the Director and if such group has recommended to the Director that such period be extended. ``(7) Authorization of appropriations.--For the purpose of carrying out this subsection, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2001 through 2005.''. TITLE III--JUVENILE ARTHRITIS AND RELATED CONDITIONS SEC. 301. NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES; RESEARCH ON JUVENILE ARTHRITIS AND RELATED CONDITIONS. (a) In General.--Subpart 4 of part C of title IV of the Public Health Service Act (42 U.S.C. 285d et seq.) is amended by inserting after section 442 the following section: ``juvenile arthritis and related conditions ``Sec. 442A. (a) Expansion and Coordination of Activities.--The Director of the Institute, in coordination with the Director of the National Institute of Allergy and Infectious Diseases, shall expand and intensify the programs of such Institutes with respect to research and related activities concerning juvenile arthritis and related conditions. ``(b) Coordination.--The Directors referred to in subsection (a) shall jointly coordinate the programs referred to in such subsection and consult with the Arthritis and Musculoskeletal Diseases Interagency Coordinating Committee. ``(c) Authorization of Appropriations.--For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2001 through 2005.''. (b) Pediatric Rheumatology.--Subpart 1 of part E of title VII of the Public Health Service Act (42 U.S.C. 294n et seq.) is amended by adding at the end the following: ``SEC. 763. PEDIATRIC RHEUMATOLOGY. ``(a) In General.--The Secretary, acting through the appropriate agencies, shall evaluate whether the number of pediatric rheumatologists is sufficient to address the health care needs of children with arthritis and related conditions, and if the Secretary determines that the number is not sufficient, shall develop strategies to help address the shortfall. ``(b) Report to Congress.--Not later than October 1, 2001, the Secretary shall submit to the Congress a report describing the results of the evaluation under subsection (a), and as applicable, the strategies developed under such subsection. ``(c) Authorization of Appropriations.--For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2001 through 2005.''. SEC. 302. INFORMATION CLEARINGHOUSE. Section 438(b) of the Public Health Service Act (42 U.S.C. 285d-3(b)) is amended by inserting ``, including juvenile arthritis and related conditions,'' after ``diseases''. TITLE IV--REDUCING BURDEN OF DIABETES AMONG CHILDREN AND YOUTH SEC. 401. PROGRAMS OF CENTERS FOR DISEASE CONTROL AND PREVENTION. Part B of title III of the Public Health Service Act (42 U.S.C. 243 et seq.) is amended by inserting after section 317G the following section: ``diabetes in children and youth ``Sec. 317H. (a) Surveillance on Juvenile Diabetes.--The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall develop a sentinel system to collect data on juvenile diabetes, including with respect to incidence and prevalence, and shall establish a national database for such data. ``(b) Type 2 Diabetes in Youth.--The Secretary shall implement a national public health effort to address type 2 diabetes in youth, including-- ``(1) enhancing surveillance systems and expanding research to better assess the prevalence and incidence of type 2 diabetes in youth and determine the extent to which type 2 diabetes is incorrectly diagnosed as type 1 diabetes among children; and ``(2) developing and improving laboratory methods to assist in diagnosis, treatment, and prevention of diabetes including, but not limited to, developing noninvasive ways to monitor blood glucose to prevent hypoglycemia and improving existing glucometers that measure blood glucose. ``(c) Authorization of Appropriations.--For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2001 through 2005.''. SEC. 402. PROGRAMS OF NATIONAL INSTITUTES OF HEALTH. Subpart 3 of part C of title IV of the Public Health Service Act (42 U.S.C. 285c et seq.) is amended by inserting after section 434 the following section: ``juvenile diabetes ``Sec. 434A. (a) Long-Term Epidemiology Studies.--The Director of the Institute shall conduct or support long-term epidemiology studies in which individuals with or at risk for type 1, or juvenile, diabetes are followed for 10 years or more. Such studies shall investigate the causes and characteristics of the disease and its complications. ``(b) Clinical Trial Infrastructure/Innovative Treatments for Juvenile Diabetes.--The Secretary, acting through the Director of the National Institutes of Health, shall support regional clinical research centers for the prevention, detection, treatment, and cure of juvenile diabetes. ``(c) Prevention of Type 1 Diabetes.--The Secretary, acting through the appropriate agencies, shall provide for a national effort to prevent type 1 diabetes. Such effort shall provide for a combination of increased efforts in research and development of prevention strategies, including consideration of vaccine development, coupled with appropriate ability to test the effectiveness of such strategies in large clinical trials of children and young adults. ``(d) Authorization of Appropriations.--For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2001 through 2005.''. TITLE V--ASTHMA SERVICES FOR CHILDREN Subtitle A--Asthma Services SEC. 501. GRANTS FOR CHILDREN'S ASTHMA RELIEF. Title III of the Public Health Service Act (42 U.S.C. 241 et seq.) is amended by adding at the end the following part: ``PART P--ADDITIONAL PROGRAMS ``SEC. 399L. CHILDREN'S ASTHMA TREATMENT GRANTS PROGRAM. ``(a) Authority To Make Grants.-- ``(1) In general.--In addition to any other payments made under this Act or title V of the Social Security Act, the Secretary shall award grants to eligible entities to carry out the following purposes: ``(A) To provide access to quality medical care for children who live in areas that have a high prevalence of asthma and who lack access to medical care. ``(B) To provide on-site education to parents, children, health care providers, and medical teams to recognize the signs and symptoms of asthma, and to train them in the use of medications to treat asthma and prevent its exacerbations. ``(C) To decrease preventable trips to the emergency room by making medication available to individuals who have not previously had access to treatment or education in the management of asthma. ``(D) To provide other services, such as smoking cessation programs, home modification, and other direct and support services that ameliorate conditions that exacerbate or induce asthma. ``(2) Certain projects.--In making grants under paragraph (1), the Secretary may make [[Page H8213]] grants designed to develop and expand the following projects: ``(A) Projects to provide comprehensive asthma services to children in accordance with the guidelines of the National Asthma Education and Prevention Program (through the National Heart, Lung and Blood Institute), including access to care and treatment for asthma in a community-based setting. ``(B) Projects to fully equip mobile health care clinics that provide preventive asthma care including diagnosis, physical examinations, pharmacological therapy, skin testing, peak flow meter testing, and other asthma-related health care services. ``(C) Projects to conduct validated asthma management education programs for patients with asthma and their families, including patient education regarding asthma management, family education on asthma management, and the distribution of materials, including displays and videos, to reinforce concepts presented by medical teams. ``(2) Award of grants.-- ``(A) Application.-- ``(i) In general.--An eligible entity shall submit an application to the Secretary for a grant under this section in such form and manner as the Secretary may require. ``(ii) Required information.--An application submitted under this subparagraph shall include a plan for the use of funds awarded under the grant and such other information as the Secretary may require. ``(B) Requirement.--In awarding grants under this section, the Secretary shall give preference to eligible entities that demonstrate that the activities to be carried out under this section shall be in localities within areas of known or suspected high prevalence of childhood asthma or high asthma- related mortality or high rate of hospitalization or emergency room visits for asthma (relative to the average asthma prevalence rates and associated mortality rates in the United States). Acceptable data sets to demonstrate a high prevalence of childhood asthma or high asthma-related mortality may include data from Federal, State, or local vital statistics, claims data under title XIX or XXI of the Social Security Act, other public health statistics or surveys, or other data that the Secretary, in consultation with the Director of the Centers for Disease Control and Prevention, deems appropriate. ``(3) Definition of eligible entity.--For purposes of this section, the term `eligible entity' means a public or nonprofit private entity (including a State or political subdivision of a State), or a consortium of any of such entities. ``(b) Coordination With Other Children's Programs.--An eligible entity shall identify in the plan submitted as part of an application for a grant under this section how the entity will coordinate operations and activities under the grant with-- ``(1) other programs operated in the State that serve children with asthma, including any such programs operated under titles V, XIX, or XXI of the Social Security Act; and ``(2) one or more of the following-- ``(A) the child welfare and foster care and adoption assistance programs under parts B and E of title IV of such Act; ``(B) the head start program established under the Head Start Act (42 U.S.C. 9831 et seq.); ``(C) the program of assistance under the special supplemental nutrition program for women, infants and children (WIC) under section 17 of the Child Nutrition Act of 1966 (42 U.S.C. 1786); ``(D) local p

Major Actions:

All articles in House section

CHILDREN'S HEALTH ACT OF 2000
(House of Representatives - September 27, 2000)

Text of this article available as: TXT PDF [Pages H8206-H8265] CHILDREN'S HEALTH ACT OF 2000 Ms. PRYCE of Ohio. Mr. Speaker, by direction of the Committee on Rules, I call up House Resolution 594 and ask for its immediate consideration. The Clerk read the resolution, as follows: H. Res. 594 Resolved, That upon adoption of this resolution it shall be in order to take from the [[Page H8207]] Speaker's table the bill (H.R. 4365) to amend the Public Health Service Act with respect to children's health, with Senate amendment thereto, and to consider in the House, without intervention of any point of order, a motion offered by the chairman of the Committee on Commerce or his designee that the House concur in the Senate amendment. The Senate amendment and the motion shall be considered as read. The motion shall be debatable for one hour equally divided and controlled by the chairman and ranking minority member of the Committee on Commerce. The previous question shall be considered as ordered on the motion to final adoption without intervening motion. The SPEAKER pro tempore (Mr. Ose). The gentlewoman from Ohio (Ms. Pryce) is recognized for 1 hour. Ms. PRYCE of Ohio. Mr. Speaker, for the purpose of debate only, I yield the customary 30 minutes to the gentleman from Texas (Mr. Frost); pending which I yield myself such time as I may consume. During consideration of the resolution, all time yielded is for the purpose of debate only. Mr. Speaker, House Resolution 594 is a rule waiving all points of order against a motion to concur in the Senate amendment to H.R. 4365, the Children's Health Act of the year 2000. The rule provides 1 hour of debate on the motion to be equally divided and controlled by the chairman and ranking minority member of the Committee on Commerce. Mr. Speaker, H.R. 4365, the Children's Health Act of 2000, was passed in the House earlier this year on May 9 by a vote of 419 to two. Last week, our colleagues in the other body considered and passed this important legislation with an amendment by unanimous consent. Adoption of this rule and passage of this legislation today is the last step in our work to sending this bill to the President for his signature and thus making this important package a reality. I would like to congratulate the gentleman from Florida (Mr. Bilirakis) and the gentleman from Ohio (Mr. Brown) for their renewed efforts and success on this important legislation and also to commend the gentleman from Virginia (Mr. Bliley), chairman of the Committee on Commerce and the gentleman from Michigan (Mr. Dingell), ranking member, for their hard work and leadership. H.R. 4365, along with the decisions made by the other body, is a comprehensive package of several important children's health bills. Together it addresses a wide variety of critical issues, including day care safety, maternal and infant health, pediatric public health promotion, pediatric research, along with efforts to fight youth drug abuse and provide mental health services. {time} 1030 The legislation includes two important divisions. Division A addresses issues regarding children's health; while Division B focuses on youth drug abuse. Together this package will form the foundation for efforts to address the unique needs of one of our most important constituencies: Our children. The provisions contained in the second part of this legislation, Division D, include a number of provisions previously introduced and considered in the House of Representatives and will allow us to tackle the plague of drug abuse and addiction which are moving through many of our communities. The 1999 National Household Survey on drug abuse reported that some 10.9 percent of our youths, between the ages of 12 and 17, use some form of illicit drug. Just as tragic are the report's findings that alcohol use is also on the rise with our Nation's youth, with some 10.4 million drinkers under the legal age of 21. H.R. 4365 reauthorizes and improves the Substance Abuse and Mental Health Services Administration, SAMSHA, by giving it greater focus on our youth and increased flexibility and accountability for the States. It will provide the needed funds for community-based programs, helping individuals with substance abuse and mental health disorders. It includes the Drug Addiction Treatment Act, introduced by the gentleman from Virginia (Mr. Bliley), to permit qualified physicians to treat their addicted patients and speed up the drug approval process of narcotic drugs needed for additional treatment. Finally, H.R. 4365 includes important provisions to reduce the proliferation of the drug methamphetamine, and tackle the devastating drug currently on the rise with our youth commonly known as Ecstasy. Mr. Speaker, we all hope that the wealth of our Nation and the amazing technological advances that have been made in medicine will give us the necessary resources to protect our children from harm. We have made tremendous progress, but the sad fact is that there are still so many diseases that affect our children for which there is no cure or even an effective treatment. Division A of the legislation before us will give child victims and their families hope by devoting more Federal resources to diseases such as autism, asthma, juvenile diabetes and arthritis. I am especially pleased that this new version of H.R. 4365 includes specific provisions on childhood cancer. By awarding grants, expanding data collection, encouraging uniform reporting standards and urging the national coordination of activities, this bill will go a long way in the battle against this disease that takes the lives of so many of our Nation's children. This legislation also focuses on a new pediatric research initiative at NIH, and reauthorizes money to train physicians at children's hospitals, in order to help us better understand the way in which diseases attack children and how to give them the most effective and appropriate care. There are critical differences between medical care for adults and medical care for children that must be reflected in the training of physicians and treatments designed for a child's system, which is still developing. The children's hospitals across the Nation need funding to adequately train their physicians, and I am so very pleased that H.R. 4365 extends the authorization of appropriations for graduate medical education programs in children's hospitals through fiscal year 2005. This is an issue of fairness, and full authorization is necessary to provide children's hospitals support that is on par with that received by teaching hospitals that care for adults. This legislation recognizes and focuses on these many important differences. Mr. Speaker, while we may never be able to make a child understand why he or she is sick or is made to suffer, we can invest in the research that will allow our best and brightest scientists to solve the mysteries of childhood disease so that more children can have the carefree youths to which they are entitled. What better way to invest our Nation's resources? Mr. Speaker, this measure is straightforward and noncontroversial and its adoption will allow us to complete the work and the business of the House and pass this comprehensive package. I urge all my colleagues to support both the rule and this very important child health initiative. Mr. Speaker, I reserve the balance of my time. Mr. FROST. Mr. Speaker, I yield myself such time as I may consume. As the gentlewoman has explained, this rule will take a Senate amendment from the Speaker's desk and agree to it. Under this procedure, there will be no opportunity to change the bill under consideration with a motion to recommit. Mr. Speaker, 6 years after the Republican majority took control of this House, the Republican leadership has yet to find a way to effectively manage the business of the House. It is 3 days before the end of the fiscal year and 9 days before the Congress is scheduled to end, yet only 2 of the 13 appropriation bills have been sent to the President to be signed; we have yet to consider on this floor the funding bills we need to help people find housing or have safe transportation to get to work or plow their ground to produce food or learn the basic skills to be able to get and hold a job in the modern day workplace. Last night, the members of the Committee on Rules were held hostage for hours past the last vote so that we might be available to bail out the Republican leadership so that the House might have some business to conduct today. Why should the Committee on Rules be held here until 9:30? For one very simple reason, Mr. Speaker. And that is because the majority party still has not figured out how to run this institution in an efficient manner and [[Page H8208]] could not find anything to do on the floor today. However, sometime around 9 p.m. the Republican leadership came up with a solution. So what did they do? The Republican leadership has taken one of the bills that was supposed to be considered yesterday under procedures for noncontroversial bills, suspension of the rules, and moved it to today to be considered under a rule. I do not mean to take anything away from the value of this bill. The Children's Health Act is vitally important to help find new ways to prevent or cure diseases which affect our children. But it should have been passed last night under suspension of the rules, as it was intended to be done. The health organizations, including the March of Dimes, the Spina Bifida Foundation, the Autism Society of America, the Association of Maternal and Child Health Programs, the Epilepsy Foundation, the Cereberal Palsy Association, and many, many others have worked hard to see the bill to completion and were counting on us to do our work. It is past time to get on with this business. Mr. Speaker, I strongly support the Children's Health Act of 2000. This bill now spans 400 pages and has two basic purposes. The first addresses a host of specific childhood health problems and prenatal risk factors, including many provisions which passed in the House earlier this year. The bill authorizes research and public health and health education services that respond to fragile X syndrome, epilepsy, asthma, childhood lead poisoning, pediatric cancers, childhood obesity prevention, traumatic brain injury, juvenile diabetes, hearing loss, oral health, autism, arthritis, muscular dystrophy, autoimmune conditions, child care safety and pediatric organ transplants. It also provides block grants to the States for laboratory infrastructure and patient care services for those affected with or at risk for genetic conditions. The bill contains the first ever authorization of the very successful Healthy Start demonstration project, now in their ninth year of reducing infant mortality and improving pregnancy outcomes in underserved populations. The second feature of this bill covers a wide range of youth drug and mental health service programs that will strengthen America's communities, including extending and reauthorizing programs administered by the Substance Abuse and Mental Health Services Administration. These programs provide critical safety net services for individuals and families with substance abuse problems and mental illness, and also exclusively target youth. It also supports public and professional education programs related to substance abuse and mental illness. The breadth of services provided here range from an underage drinking provision and a suicide prevention initiative, to services for youth offenders, the homeless, and adults with fetal alcohol syndrome. This large and complex bill, however, is marked with a number of procedural irregularities. As worthy as the goals may be, no bill of this scope and magnitude should proceed to the floor without going through the committee process, yet this occurred in the majority's apparent rush to move this bill to the floor. For example, the bill contains a provision that invokes charitable choice. This is a difficult issue for many Members, yet the Committee on the Judiciary was never given the opportunity for public debate on this issue. I know this is of particular concern to my colleague, the gentleman from Virginia (Mr. Scott), who is here to voice his concerns this morning. The second example is marked with some irony. The fine provision promoting safe motherhood includes a public education initiative addressing the dangers of alcohol, tobacco and illicit drug use in pregnancy. Most women do not begin smoking during pregnancy, they begin as adolescents. Yet neither the House nor the Committee on Commerce had the opportunity to even debate the issue of FDA regulation of youth tobacco use during this Congress. I will vote for this bill, however, I want America's children to know that while H.R. 4365 is a measurable step toward improving the quality of their collective health, we can and should do better. It is obvious that this Congress will fail to address many major health care issues that confront us. I am only grateful we have the opportunity to vote for this bill and do something constructive to improve the health care of our Nation's children. Mr. Speaker, I yield 3 minutes to the gentleman from Virginia (Mr. Scott). Mr. SCOTT. Mr. Speaker, I thank the gentleman for yielding me this time, and I rise to oppose the rule because, in its present form, good health care for children now includes a bad crime bill and a provision which waters down our fundamental civil rights. A good child health care bill should not come at such a price. By adopting the rule, we will prohibit amendments to the bill that could fix the methamphetamine drug part of the bill. A similar bill was considered in the Committee on the Judiciary, and amendments could have conformed that 46-page bill to the formal deliberations of the committee. But the rule prohibits amendments, and so the bill now provides new Draconian mandatory minimums for violations of methamphetamines, mandatory minimums that everyone knows do not work. The same mandatory minimums as for crack cocaine. Now, it is interesting that crack cocaine is prevalent in the black community; methamphetamine is more prevalent in the Hispanic community. They get the Draconian mandatory minimums. However, there is an exception to all of this. Ecstasy, which is prevalent in the middle class white community, does not suffer the same mandatory minimums. The Committee on the Judiciary at least had the common decency to make them all equal. But now we have a rule which prohibits any consideration for equalizing this penalty. We have this exemption and, because of the rule, we have to just do it. The rule also protects another form of discrimination: Religious discrimination. Section 3305 has a provision that allows some sponsors of federally funded programs to discriminate on employment based on religion. That is they can tell otherwise qualified individuals that they do not hire their kind because of their religion. These are federally funded programs. We cannot address this discrimination because the rule protects that provision and does not allow any amendments. So if we want good child health care, we have to accept the discrimination; we have to accept the mandatory minimums, with the exception for the middle class white kids. We should not be forced to accept ineffective counterproductive mandatory minimums and religious discrimination as a price for good child health care, and that is why I oppose this rule. Mr. FROST. Mr. Speaker, I yield 2 minutes to the gentleman from New Jersey (Mr. Pascrell). (Mr. PASCRELL asked and was given permission to revise and extend his remarks.) Mr. PASCRELL. Mr. Speaker, I thank the gentleman from Texas for yielding me this time. Mr. Speaker, I am thrilled that the Children's Health Act of 2000 is on the floor today. I would like to thank the Chair of the Subcommittee on Health and the Environment, the gentleman from Florida (Mr. Bilirakis), and the ranking member, the gentleman from Ohio (Mr. Brown), for their leadership and determination to see the bill through. But I want to take special time to salute the gentleman from Pennsylvania (Mr. Greenwood) for his work on behalf of children in America. The gentleman from Pennsylvania has worked tirelessly on behalf of millions of Americans suffering from traumatic brain injury. He has also assisted in my efforts to create the first national traumatic brain injury registry, which is critical. I first became involved with this issue several years ago when a constituent of mine, Dennis Benigno, approached me to tell me about his son, who was struck by a car, hospitalized for months, leaving him with severe cognitive and physical damage. {time} 1045 As a result of his son's accident, Mr. Benigno has been on the front lines researching the disease, informing others, reaching out to the medical research and scientific community, and lobbying elected officials like myself. I am proud of the efforts and the progress my good friend has made on [[Page H8209]] behalf of traumatic brain injury, and I am pleased that the national registry will be included in the Children's Health Act. These brain injury registries will also charge hospitals and local and State departments of health with the task of collecting data for up to a year following the injury. A national registry will help all of us to better understand the injury, what types of treatment people have received, what services they use, and how we can best link people with services. I also hope that we fight each day, like Dennis does, to raise awareness of this disease and to fight for the injured, like his son. I urge all my colleagues to, when the bill comes up after we debate the rule, vote for the passage of this bill. Ms. PRYCE of Ohio. Mr. Speaker, I reserve the balance of my time. Mr. FROST. Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, as I indicated in my opening remarks, this is a good bill. The gentleman from Virginia (Mr. Scott) has some legitimate concerns about a particular matter that he was not able to address. The overall bill is an important piece of legislation. We have concerns on this side that we seem to be treading water here in not being able to bring anything up on the floor on a regular basis. We do not know from day to day what is going to be considered. This bill could have been done on suspension yesterday. That does not diminish the bill. This is an important piece of legislation. I support the bill and support the rule. Mr. Speaker, I yield back the balance of my time. Ms. PRYCE of Ohio. Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, in closing, let me just respond. This very well could have been considered under the suspension calendar last night. We would all have been considering this bill at about 11 p.m. if that were the case. Instead, we chose to come back in the light of day and with everyone well rested and alert and consider this important piece of legislation and allow the American public to hear all the goods things that we are promoting and adopting. In closing, let me remind my colleagues that the House has already passed this with a strong bipartisan support vote of 419-2. Our work today will allow us to dedicate important resources and focus Members on the very unique needs in the health and well-being of our children. I urge adoption of this straightforward, noncontroversial rule and passage of the comprehensive legislation. I applaud my colleagues, the gentleman from Florida (Chairman Bilirakis), and my colleague, the gentleman from Ohio (Mr. Brown), on their hard work. Mr. Speaker, I yield back the balance of my time, and I move the previous question on the resolution. The previous question was ordered. The resolution was agreed to. A motion to reconsider was laid on the table. Mr. BILIRAKIS. Mr. Speaker, pursuant to House Resolution 594, I call up from the Speaker's table the bill (H.R. 4365) to amend the Public Health Service Act with respect to children's health, with the Senate amendment thereto, and ask for its immediate consideration. The Clerk read the title of the bill. Motion Offered by Mr. Bilirakis Mr. BILIRAKIS. Mr. Speaker, I offer a motion. The SPEAKER pro tempore (Mr. Ose). The Clerk will designate the motion. The text of the motion is as follows: Mr. Bilirakis moves that the House concur in the Senate amendment to H.R. 4365, as follows: Senate amendment: Strike out all after the enacting clause and insert: SECTION 1. SHORT TITLE. This Act may be cited as the ``Children's Health Act of 2000''. SEC. 2. TABLE OF CONTENTS. The table of contents for this Act is as follows: Sec. 1. Short title. Sec. 2. Table of contents. DIVISION A--CHILDREN'S HEALTH TITLE I--AUTISM Sec. 101. Expansion, intensification, and coordination of activities of National Institutes of Health with respect to research on autism. Sec. 102. Developmental disabilities surveillance and research programs. Sec. 103. Information and education. Sec. 104. Inter-agency Autism Coordinating Committee. Sec. 105. Report to Congress. TITLE II--RESEARCH AND DEVELOPMENT REGARDING FRAGILE X Sec. 201. National Institute of Child Health and Human Development; research on fragile X. TITLE III--JUVENILE ARTHRITIS AND RELATED CONDITIONS Sec. 301. National Institute of Arthritis and Musculoskeletal and Skin Diseases; research on juvenile arthritis and related conditions. Sec. 302. Information clearinghouse. TITLE IV--REDUCING BURDEN OF DIABETES AMONG CHILDREN AND YOUTH Sec. 401. Programs of Centers for Disease Control and Prevention. Sec. 402. Programs of National Institutes of Health. TITLE V--ASTHMA SERVICES FOR CHILDREN Subtitle A--Asthma Services Sec. 501. Grants for children's asthma relief. Sec. 502. Technical and conforming amendments. Subtitle B--Prevention Activities Sec. 511. Preventive health and health services block grant; systems for reducing asthma-related illnesses through integrated pest management. Subtitle C--Coordination of Federal Activities Sec. 521. Coordination through National Institutes of Health. Subtitle D--Compilation of Data Sec. 531. Compilation of data by Centers for Disease Control and Prevention. TITLE VI--BIRTH DEFECTS PREVENTION ACTIVITIES Subtitle A--Folic Acid Promotion Sec. 601. Program regarding effects of folic acid in prevention of birth defects. Subtitle B--National Center on Birth Defects and Developmental Disabilities Sec. 611. National Center on Birth Defects and Developmental Disabilities. TITLE VII--EARLY DETECTION, DIAGNOSIS, AND TREATMENT REGARDING HEARING LOSS IN INFANTS Sec. 701. Purposes. Sec. 702. Programs of Health Resources and Services Administration, Centers for Disease Control and Prevention, and National Institutes of Health. TITLE VIII--CHILDREN AND EPILEPSY Sec. 801. National public health campaign on epilepsy; seizure disorder demonstration projects in medically underserved areas. TITLE IX--SAFE MOTHERHOOD; INFANT HEALTH PROMOTION Subtitle A--Safe Motherhood Prevention Research Sec. 901. Prevention research and other activities. Subtitle B--Pregnant Women and Infants Health Promotion Sec. 911. Programs regarding prenatal and postnatal health. TITLE X--PEDIATRIC RESEARCH INITIATIVE Sec. 1001. Establishment of pediatric research initiative. Sec. 1002. Investment in tomorrow's pediatric researchers. Sec. 1003. Review of regulations. Sec. 1004. Long-term child development study. TITLE XI--CHILDHOOD MALIGNANCIES Sec. 1101. Programs of Centers for Disease Control and Prevention and National Institutes of Health. TITLE XII--ADOPTION AWARENESS Subtitle A--Infant Adoption Awareness Sec. 1201. Grants regarding infant adoption awareness. Subtitle B--Special Needs Adoption Awareness Sec. 1211. Special needs adoption programs; public awareness campaign and other activities. TITLE XIII--TRAUMATIC BRAIN INJURY Sec. 1301. Programs of Centers for Disease Control and Prevention. Sec. 1302. Study and monitor incidence and prevalence. Sec. 1303. Programs of National Institutes of Health. Sec. 1304. Programs of Health Resources and Services Administration. Sec. 1305. State grants for protection and advocacy services. Sec. 1306. Authorization of appropriations for certain programs. TITLE XIV--CHILD CARE SAFETY AND HEALTH GRANTS Sec. 1401. Definitions. Sec. 1402. Authorization of appropriations. Sec. 1403. Programs. Sec. 1404. Amounts reserved; allotments. Sec. 1405. State applications. Sec. 1406. Use of funds. Sec. 1407. Reports. TITLE XV--HEALTHY START INITIATIVE Sec. 1501. Continuation of healthy start program. [[Page H8210]] TITLE XVI--ORAL HEALTH PROMOTION AND DISEASE PREVENTION Sec. 1601. Identification of interventions that reduce the burden and transmission of oral, dental, and craniofacial diseases in high risk populations; development of approaches for pediatric oral and craniofacial assessment. Sec. 1602. Oral health promotion and disease prevention. Sec. 1603. Coordinated program to improve pediatric oral health. TITLE XVII--VACCINE-RELATED PROGRAMS Subtitle A--Vaccine Compensation Program Sec. 1701. Content of petitions. Subtitle B-- Childhood Immunizations Sec. 1711. Childhood immunizations. TITLE XVIII--HEPATITIS C Sec. 1801. Surveillance and education regarding hepatitis C. TITLE XIX--NIH INITIATIVE ON AUTOIMMUNE DISEASES Sec. 1901. Autoimmune diseases; initiative through Director of National Institutes of Health. TITLE XX--GRADUATE MEDICAL EDUCATION PROGRAMS IN CHILDREN'S HOSPITALS Sec. 2001. Provisions to revise and extend program. TITLE XXI--SPECIAL NEEDS OF CHILDREN REGARDING ORGAN TRANSPLANTATION Sec. 2101. Organ Procurement and Transplantation Network; amendments regarding needs of children. TITLE XXII--MUSCULAR DYSTROPHY RESEARCH Sec. 2201. Muscular dystrophy research. TITLE XXIII--CHILDREN AND TOURETTE SYNDROME AWARENESS Sec. 2301. Grants regarding Tourette Syndrome. TITLE XXIV--CHILDHOOD OBESITY PREVENTION Sec. 2401. Programs operated through the Centers for Disease Control and Prevention. TITLE XXV--EARLY DETECTION AND TREATMENT REGARDING CHILDHOOD LEAD POISONING Sec. 2501. Centers for Disease Control and Prevention efforts to combat childhood lead poisoning. Sec. 2502. Grants for lead poisoning related activities. Sec. 2503. Training and reports by the Health Resources and Services Administration. Sec. 2504. Screenings, referrals, and education regarding lead poisoning. TITLE XXVI--SCREENING FOR HERITABLE DISORDERS Sec. 2601. Program to improve the ability of States to provide newborn and child screening for heritable disorders. TITLE XXVII--PEDIATRIC RESEARCH PROTECTIONS Sec. 2701. Requirement for additional protections for children involved in research. TITLE XXVIII--MISCELLANEOUS PROVISIONS Sec. 2801. Report regarding research on rare diseases in children. Sec. 2802. Study on metabolic disorders. TITLE XXIX--EFFECTIVE DATE Sec. 2901. Effective date. DIVISION B--YOUTH DRUG AND MENTAL HEALTH SERVICES Sec. 3001. Short title. TITLE XXXI--PROVISIONS RELATING TO SERVICES FOR CHILDREN AND ADOLESCENTS Sec. 3101. Children and violence. Sec. 3102. Emergency response. Sec. 3103. High risk youth reauthorization. Sec. 3104. Substance abuse treatment services for children and adolescents. Sec. 3105. Comprehensive community services for children with serious emotional disturbance. Sec. 3106. Services for children of substance abusers. Sec. 3107. Services for youth offenders. Sec. 3108. Grants for strengthening families through community partnerships. Sec. 3109. Programs to reduce underage drinking. Sec. 3110. Services for individuals with fetal alcohol syndrome. Sec. 3111. Suicide prevention. Sec. 3112. General provisions. TITLE XXXII--PROVISIONS RELATING TO MENTAL HEALTH Sec. 3201. Priority mental health needs of regional and national significance. Sec. 3202. Grants for the benefit of homeless individuals. Sec. 3203. Projects for assistance in transition from homelessness. Sec. 3204. Community mental health services performance partnership block grant. Sec. 3205. Determination of allotment. Sec. 3206. Protection and Advocacy for Mentally Ill Individuals Act of 1986. Sec. 3207. Requirement relating to the rights of residents of certain facilities. Sec. 3208. Requirement relating to the rights of residents of certain non-medical, community-based facilities for children and youth. Sec. 3209. Emergency mental health centers. Sec. 3210. Grants for jail diversion programs. Sec. 3211. Improving outcomes for children and adolescents through services integration between child welfare and mental health services. Sec. 3212. Grants for the integrated treatment of serious mental illness and co-occurring substance abuse. Sec. 3213. Training grants. TITLE XXXIII--PROVISIONS RELATING TO SUBSTANCE ABUSE Sec. 3301. Priority substance abuse treatment needs of regional and national significance. Sec. 3302. Priority substance abuse prevention needs of regional and national significance. Sec. 3303. Substance abuse prevention and treatment performance partnership block grant. Sec. 3304. Determination of allotments. Sec. 3305. Nondiscrimination and institutional safeguards for religious providers. Sec. 3306. Alcohol and drug prevention or treatment services for Indians and Native Alaskans. Sec. 3307. Establishment of commission. TITLE XXXIV--PROVISIONS RELATING TO FLEXIBILITY AND ACCOUNTABILITY Sec. 3401. General authorities and peer review. Sec. 3402. Advisory councils. Sec. 3403. General provisions for the performance partnership block grants. Sec. 3404. Data infrastructure projects. Sec. 3405. Repeal of obsolete addict referral provisions. Sec. 3406. Individuals with co-occurring disorders. Sec. 3407. Services for individuals with co-occurring disorders. TITLE XXXV--WAIVER AUTHORITY FOR PHYSICIANS WHO DISPENSE OR PRESCRIBE CERTAIN NARCOTIC DRUGS FOR MAINTENANCE TREATMENT OR DETOXIFICATION TREATMENT Sec. 3501. Short title. Sec. 3502. Amendment to Controlled Substances Act. TITLE XXXVI--METHAMPHETAMINE AND OTHER CONTROLLED SUBSTANCES Sec. 3601. Short title. Subtitle A--Methamphetamine Production, Trafficking, and Abuse Part I--Criminal Penalties Sec. 3611. Enhanced punishment of amphetamine laboratory operators. Sec. 3612. Enhanced punishment of amphetamine or methamphetamine laboratory operators. Sec. 3613. Mandatory restitution for violations of Controlled Substances Act and Controlled Substances Import and Export Act relating to amphetamine and methamphetamine. Sec. 3614. Methamphetamine paraphernalia. Part II--Enhanced Law Enforcement Sec. 3621. Environmental hazards associated with illegal manufacture of amphetamine and methamphetamine. Sec. 3622. Reduction in retail sales transaction threshold for non-safe harbor products containing pseudoephedrine or phenylpropanolamine. Sec. 3623. Training for Drug Enforcement Administration and State and local law enforcement personnel relating to clandestine laboratories. Sec. 3624. Combating methamphetamine and amphetamine in high intensity drug trafficking areas. Sec. 3625. Combating amphetamine and methamphetamine manufacturing and trafficking. Part III--Abuse Prevention and Treatment Sec. 3631. Expansion of methamphetamine research. Sec. 3632. Methamphetamine and amphetamine treatment initiative by Center for Substance Abuse Treatment. Sec. 3633. Study of methamphetamine treatment. Part IV--Reports Sec. 3641. Reports on consumption of methamphetamine and other illicit drugs in rural areas, metropolitan areas, and consolidated metropolitan areas. Sec. 3642. Report on diversion of ordinary, over-the-counter pseudoephedrine and phenylpropanolamine products. Subtitle B--Controlled Substances Generally Sec. 3651. Enhanced punishment for trafficking in list I chemicals. Sec. 3652. Mail order requirements. Sec. 3653. Theft and transportation of anhydrous ammonia for purposes of illicit production of controlled substances. Subtitle C--Ecstasy Anti-Proliferation Act of 2000 Sec. 3661. Short title. Sec. 3662. Findings. Sec. 3663. Enhanced punishment of Ecstasy traffickers. Sec. 3664. Emergency authority to United States Sentencing Commission. Sec. 3665. Expansion of Ecstasy and club drugs abuse prevention efforts. Subtitle D--Miscellaneous Sec. 3671. Antidrug messages on Federal Government Internet websites. Sec. 3672. Reimbursement by Drug Enforcement Administration of expenses incurred to remediate methamphetamine laboratories. Sec. 3673. Severability. [[Page H8211]] DIVISION A--CHILDREN'S HEALTH TITLE I--AUTISM SEC. 101. EXPANSION, INTENSIFICATION, AND COORDINATION OF ACTIVITIES OF NATIONAL INSTITUTES OF HEALTH WITH RESPECT TO RESEARCH ON AUTISM. Part B of title IV of the Public Health Service Act (42 U.S.C. 284 et seq.) is amended by adding at the end the following section: ``expansion, intensification, and coordination of activities of national institutes of health with respect to research on autism ``Sec. 409C. (a) In General.-- ``(1) Expansion of activities.--The Director of NIH (in this section referred to as the `Director') shall expand, intensify, and coordinate the activities of the National Institutes of Health with respect to research on autism. ``(2) Administration of program; collaboration among agencies.--The Director shall carry out this section acting through the Director of the National Institute of Mental Health and in collaboration with any other agencies that the Director determines appropriate. ``(b) Centers of Excellence.-- ``(1) In general.--The Director shall under subsection (a)(1) make awards of grants and contracts to public or nonprofit private entities to pay all or part of the cost of planning, establishing, improving, and providing basic operating support for centers of excellence regarding research on autism. ``(2) Research.--Each center under paragraph (1) shall conduct basic and clinical research into autism. Such research should include investigations into the cause, diagnosis, early detection, prevention, control, and treatment of autism. The centers, as a group, shall conduct research including the fields of developmental neurobiology, genetics, and psychopharmacology. ``(3) Services for patients.-- ``(A) In general.--A center under paragraph (1) may expend amounts provided under such paragraph to carry out a program to make individuals aware of opportunities to participate as subjects in research conducted by the centers. ``(B) Referrals and costs.--A program under subparagraph (A) may, in accordance with such criteria as the Director may establish, provide to the subjects described in such subparagraph, referrals for health and other services, and such patient care costs as are required for research. ``(C) Availability and access.--The extent to which a center can demonstrate availability and access to clinical services shall be considered by the Director in decisions about awarding grants to applicants which meet the scientific criteria for funding under this section. ``(4) Coordination of centers; reports.--The Director shall, as appropriate, provide for the coordination of information among centers under paragraph (1) and ensure regular communication between such centers, and may require the periodic preparation of reports on the activities of the centers and the submission of the reports to the Director. ``(5) Organization of centers.--Each center under paragraph (1) shall use the facilities of a single institution, or be formed from a consortium of cooperating institutions, meeting such requirements as may be prescribed by the Director. ``(6) Number of centers; duration of support.-- ``(A) In general.--The Director shall provide for the establishment of not less than 5 centers under paragraph (1). ``(B) Duration.--Support for a center established under paragraph (1) may be provided under this section for a period of not to exceed 5 years. Such period may be extended for 1 or more additional periods not exceeding 5 years if the operations of such center have been reviewed by an appropriate technical and scientific peer review group established by the Director and if such group has recommended to the Director that such period should be extended. ``(c) Facilitation of Research.--The Director shall under subsection (a)(1) provide for a program under which samples of tissues and genetic materials that are of use in research on autism are donated, collected, preserved, and made available for such research. The program shall be carried out in accordance with accepted scientific and medical standards for the donation, collection, and preservation of such samples. ``(d) Public Input.--The Director shall under subsection (a)(1) provide for means through which the public can obtain information on the existing and planned programs and activities of the National Institutes of Health with respect to autism and through which the Director can receive comments from the public regarding such programs and activities. ``(e) Funding.--There are authorized to be appropriated such sums as may be necessary to carry out this section. Amounts appropriated under this subsection are in addition to any other amounts appropriated for such purpose.''. SEC. 102. DEVELOPMENTAL DISABILITIES SURVEILLANCE AND RESEARCH PROGRAMS. (a) National Autism and Pervasive Developmental Disabilities Surveillance Program.-- (1) In general.--The Secretary of Health and Human Services (in this section referred to as the ``Secretary''), acting through the Director of the Centers for Disease Control and Prevention, may make awards of grants and cooperative agreements for the collection, analysis, and reporting of data on autism and pervasive developmental disabilities. In making such awards, the Secretary may provide direct technical assistance in lieu of cash. (2) Eligibility.--To be eligible to receive an award under paragraph (1) an entity shall be a public or nonprofit private entity (including health departments of States and political subdivisions of States, and including universities and other educational entities). (b) Centers of Excellence in Autism and Pervasive Developmental Disabilities Epidemiology.-- (1) In general.--The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall establish not less than 3 regional centers of excellence in autism and pervasive developmental disabilities epidemiology for the purpose of collecting and analyzing information on the number, incidence, correlates, and causes of autism and related developmental disabilities. (2) Recipients of awards for establishment of centers.-- Centers under paragraph (1) shall be established and operated through the awarding of grants or cooperative agreements to public or nonprofit private entities that conduct research, including health departments of States and political subdivisions of States, and including universities and other educational entities. (3) Certain requirements.--An award for a center under paragraph (1) may be made only if the entity involved submits to the Secretary an application containing such agreements and information as the Secretary may require, including an agreement that the center involved will operate in accordance with the following: (A) The center will collect, analyze, and report autism and pervasive developmental disabilities data according to guidelines prescribed by the Director, after consultation with relevant State and local public health officials, private sector developmental disability researchers, and advocates for those with developmental disabilities. (B) The center will assist with the development and coordination of State autism and pervasive developmental disabilities surveillance efforts within a region. (C) The center will identify eligible cases and controls through its surveillance systems and conduct research into factors which may cause autism and related developmental disabilities. (D) The center will develop or extend an area of special research expertise (including genetics, environmental exposure to contaminants, immunology, and other relevant research specialty areas). (c) Clearinghouse.--The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall carry out the following: (1) The Secretary shall establish a clearinghouse within the Centers for Disease Control and Prevention for the collection and storage of data generated from the monitoring programs established by this title. Through the clearinghouse, such Centers shall serve as the coordinating agency for autism and pervasive developmental disabilities surveillance activities. The functions of such a clearinghouse shall include facilitating the coordination of research and policy development relating to the epidemiology of autism and other pervasive developmental disabilities. (2) The Secretary shall coordinate the Federal response to requests for assistance from State health department officials regarding potential or alleged autism or developmental disability clusters. (d) Definition.--In this title, the term ``State'' means each of the several States, the District of Columbia, the Commonwealth of Puerto Rico, American Samoa, Guam, the Commonwealth of the Northern Mariana Islands, the Virgin Islands, and the Trust Territory of the Pacific Islands. (e) Authorization of Appropriations.--There are authorized to be appropriated such sums as may be necessary to carry out this section. SEC. 103. INFORMATION AND EDUCATION. (a) In General.--The Secretary shall establish and implement a program to provide information and education on autism to health professionals and the general public, including information and education on advances in the diagnosis and treatment of autism and training and continuing education through programs for scientists, physicians, and other health professionals who provide care for patients with autism. (b) Stipends.--The Secretary may use amounts made available under this section to provide stipends for health professionals who are enrolled in training programs under this section. (c) Authorization of Appropriations.--There are authorized to be appropriated such sums as may be necessary to carry out this section. SEC. 104. INTER-AGENCY AUTISM COORDINATING COMMITTEE. (a) Establishment.--The Secretary shall establish a committee to be known as the ``Autism Coordinating Committee'' (in this section referred to as the ``Committee'') to coordinate all efforts within the Department of Health and Human Services concerning autism, including activities carried out through the National Institutes of Health and the Centers for Disease Control and Prevention under this title (and the amendment made by this title). (b) Membership.-- (1) In general.--The Committee shall be composed of the Directors of such national research institutes, of the Centers for Disease Control and Prevention, and of such other agencies and such other officials as the Secretary determines appropriate. (2) Additional members.--If determined appropriate by the Secretary, the Secretary may appoint to the Committee-- (A) parents or legal guardians of individuals with autism or other pervasive developmental disorders; and [[Page H8212]] (B) representatives of other governmental agencies that serve children with autism such as the Department of Education. (c) Administrative Support; Terms of Service; Other Provisions.--The following shall apply with respect to the Committee: (1) The Committee shall receive necessary and appropriate administrative support from the Department of Health and Human Services. (2) Members of the Committee appointed under subsection (b)(2)(A) shall serve for a term of 3 years, and may serve for an unlimited number of terms if reappointed. (3) The Committee shall meet not less than 2 times each year. SEC. 105. REPORT TO CONGRESS. Not later than January 1, 2001, and each January 1 thereafter, the Secretary shall prepare and submit to the appropriate committees of Congress, a report concerning the implementation of this title and the amendments made by this title. TITLE II--RESEARCH AND DEVELOPMENT REGARDING FRAGILE X SEC. 201. NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT; RESEARCH ON FRAGILE X. Subpart 7 of part C of title IV of the Public Health Service Act is amended by adding at the end the following section: ``fragile x ``Sec. 452E. (a) Expansion and Coordination of Research Activities.--The Director of the Institute, after consultation with the advisory council for the Institute, shall expand, intensify, and coordinate the activities of the Institute with respect to research on the disease known as fragile X. ``(b) Research Centers.-- ``(1) In general.--The Director of the Institute shall make grants or enter into contracts for the development and operation of centers to conduct research for the purposes of improving the diagnosis and treatment of, and finding the cure for, fragile X. ``(2) Number of centers.-- ``(A) In general.--In carrying out paragraph (1), the Director of the Institute shall, to the extent that amounts are appropriated, and subject to subparagraph (B), provide for the establishment of at least three fragile X research centers. ``(B) Peer review requirement.--The Director of the Institute shall make a grant to, or enter into a contract with, an entity for purposes of establishing a center under paragraph (1) only if the grant or contract has been recommended after technical and scientific peer review required by regulations under section 492. ``(3) Activities.--The Director of the Institute, with the assistance of centers established under paragraph (1), shall conduct and support basic and biomedical research into the detection and treatment of fragile X. ``(4) Coordination among centers.--The Director of the Institute shall, as appropriate, provide for the coordination of the activities of the centers assisted under this section, including providing for the exchange of information among the centers. ``(5) Certain administrative requirements.--Each center assisted under paragraph (1) shall use the facilities of a single institution, or be formed from a consortium of cooperating institutions, meeting such requirements as may be prescribed by the Director of the Institute. ``(6) Duration of support.--Support may be provided to a center under paragraph (1) for a period not exceeding 5 years. Such period may be extended for one or more additional periods, each of which may not exceed 5 years, if the operations of such center have been reviewed by an appropriate technical and scientific peer review group established by the Director and if such group has recommended to the Director that such period be extended. ``(7) Authorization of appropriations.--For the purpose of carrying out this subsection, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2001 through 2005.''. TITLE III--JUVENILE ARTHRITIS AND RELATED CONDITIONS SEC. 301. NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES; RESEARCH ON JUVENILE ARTHRITIS AND RELATED CONDITIONS. (a) In General.--Subpart 4 of part C of title IV of the Public Health Service Act (42 U.S.C. 285d et seq.) is amended by inserting after section 442 the following section: ``juvenile arthritis and related conditions ``Sec. 442A. (a) Expansion and Coordination of Activities.--The Director of the Institute, in coordination with the Director of the National Institute of Allergy and Infectious Diseases, shall expand and intensify the programs of such Institutes with respect to research and related activities concerning juvenile arthritis and related conditions. ``(b) Coordination.--The Directors referred to in subsection (a) shall jointly coordinate the programs referred to in such subsection and consult with the Arthritis and Musculoskeletal Diseases Interagency Coordinating Committee. ``(c) Authorization of Appropriations.--For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2001 through 2005.''. (b) Pediatric Rheumatology.--Subpart 1 of part E of title VII of the Public Health Service Act (42 U.S.C. 294n et seq.) is amended by adding at the end the following: ``SEC. 763. PEDIATRIC RHEUMATOLOGY. ``(a) In General.--The Secretary, acting through the appropriate agencies, shall evaluate whether the number of pediatric rheumatologists is sufficient to address the health care needs of children with arthritis and related conditions, and if the Secretary determines that the number is not sufficient, shall develop strategies to help address the shortfall. ``(b) Report to Congress.--Not later than October 1, 2001, the Secretary shall submit to the Congress a report describing the results of the evaluation under subsection (a), and as applicable, the strategies developed under such subsection. ``(c) Authorization of Appropriations.--For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2001 through 2005.''. SEC. 302. INFORMATION CLEARINGHOUSE. Section 438(b) of the Public Health Service Act (42 U.S.C. 285d-3(b)) is amended by inserting ``, including juvenile arthritis and related conditions,'' after ``diseases''. TITLE IV--REDUCING BURDEN OF DIABETES AMONG CHILDREN AND YOUTH SEC. 401. PROGRAMS OF CENTERS FOR DISEASE CONTROL AND PREVENTION. Part B of title III of the Public Health Service Act (42 U.S.C. 243 et seq.) is amended by inserting after section 317G the following section: ``diabetes in children and youth ``Sec. 317H. (a) Surveillance on Juvenile Diabetes.--The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall develop a sentinel system to collect data on juvenile diabetes, including with respect to incidence and prevalence, and shall establish a national database for such data. ``(b) Type 2 Diabetes in Youth.--The Secretary shall implement a national public health effort to address type 2 diabetes in youth, including-- ``(1) enhancing surveillance systems and expanding research to better assess the prevalence and incidence of type 2 diabetes in youth and determine the extent to which type 2 diabetes is incorrectly diagnosed as type 1 diabetes among children; and ``(2) developing and improving laboratory methods to assist in diagnosis, treatment, and prevention of diabetes including, but not limited to, developing noninvasive ways to monitor blood glucose to prevent hypoglycemia and improving existing glucometers that measure blood glucose. ``(c) Authorization of Appropriations.--For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2001 through 2005.''. SEC. 402. PROGRAMS OF NATIONAL INSTITUTES OF HEALTH. Subpart 3 of part C of title IV of the Public Health Service Act (42 U.S.C. 285c et seq.) is amended by inserting after section 434 the following section: ``juvenile diabetes ``Sec. 434A. (a) Long-Term Epidemiology Studies.--The Director of the Institute shall conduct or support long-term epidemiology studies in which individuals with or at risk for type 1, or juvenile, diabetes are followed for 10 years or more. Such studies shall investigate the causes and characteristics of the disease and its complications. ``(b) Clinical Trial Infrastructure/Innovative Treatments for Juvenile Diabetes.--The Secretary, acting through the Director of the National Institutes of Health, shall support regional clinical research centers for the prevention, detection, treatment, and cure of juvenile diabetes. ``(c) Prevention of Type 1 Diabetes.--The Secretary, acting through the appropriate agencies, shall provide for a national effort to prevent type 1 diabetes. Such effort shall provide for a combination of increased efforts in research and development of prevention strategies, including consideration of vaccine development, coupled with appropriate ability to test the effectiveness of such strategies in large clinical trials of children and young adults. ``(d) Authorization of Appropriations.--For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2001 through 2005.''. TITLE V--ASTHMA SERVICES FOR CHILDREN Subtitle A--Asthma Services SEC. 501. GRANTS FOR CHILDREN'S ASTHMA RELIEF. Title III of the Public Health Service Act (42 U.S.C. 241 et seq.) is amended by adding at the end the following part: ``PART P--ADDITIONAL PROGRAMS ``SEC. 399L. CHILDREN'S ASTHMA TREATMENT GRANTS PROGRAM. ``(a) Authority To Make Grants.-- ``(1) In general.--In addition to any other payments made under this Act or title V of the Social Security Act, the Secretary shall award grants to eligible entities to carry out the following purposes: ``(A) To provide access to quality medical care for children who live in areas that have a high prevalence of asthma and who lack access to medical care. ``(B) To provide on-site education to parents, children, health care providers, and medical teams to recognize the signs and symptoms of asthma, and to train them in the use of medications to treat asthma and prevent its exacerbations. ``(C) To decrease preventable trips to the emergency room by making medication available to individuals who have not previously had access to treatment or education in the management of asthma. ``(D) To provide other services, such as smoking cessation programs, home modification, and other direct and support services that ameliorate conditions that exacerbate or induce asthma. ``(2) Certain projects.--In making grants under paragraph (1), the Secretary may make [[Page H8213]] grants designed to develop and expand the following projects: ``(A) Projects to provide comprehensive asthma services to children in accordance with the guidelines of the National Asthma Education and Prevention Program (through the National Heart, Lung and Blood Institute), including access to care and treatment for asthma in a community-based setting. ``(B) Projects to fully equip mobile health care clinics that provide preventive asthma care including diagnosis, physical examinations, pharmacological therapy, skin testing, peak flow meter testing, and other asthma-related health care services. ``(C) Projects to conduct validated asthma management education programs for patients with asthma and their families, including patient education regarding asthma management, family education on asthma management, and the distribution of materials, including displays and videos, to reinforce concepts presented by medical teams. ``(2) Award of grants.-- ``(A) Application.-- ``(i) In general.--An eligible entity shall submit an application to the Secretary for a grant under this section in such form and manner as the Secretary may require. ``(ii) Required information.--An application submitted under this subparagraph shall include a plan for the use of funds awarded under the grant and such other information as the Secretary may require. ``(B) Requirement.--In awarding grants under this section, the Secretary shall give preference to eligible entities that demonstrate that the activities to be carried out under this section shall be in localities within areas of known or suspected high prevalence of childhood asthma or high asthma- related mortality or high rate of hospitalization or emergency room visits for asthma (relative to the average asthma prevalence rates and associated mortality rates in the United States). Acceptable data sets to demonstrate a high prevalence of childhood asthma or high asthma-related mortality may include data from Federal, State, or local vital statistics, claims data under title XIX or XXI of the Social Security Act, other public health statistics or surveys, or other data that the Secretary, in consultation with the Director of the Centers for Disease Control and Prevention, deems appropriate. ``(3) Definition of eligible entity.--For purposes of this section, the term `eligible entity' means a public or nonprofit private entity (including a State or political subdivision of a State), or a consortium of any of such entities. ``(b) Coordination With Other Children's Programs.--An eligible entity shall identify in the plan submitted as part of an application for a grant under this section how the entity will coordinate operations and activities under the grant with-- ``(1) other programs operated in the State that serve children with asthma, including any such programs operated under titles V, XIX, or XXI of the Social Security Act; and ``(2) one or more of the following-- ``(A) the child welfare and foster care and adoption assistance programs under parts B and E of title IV of such Act; ``(B) the head start program established under the Head Start Act (42 U.S.C. 9831 et seq.); ``(C) the program of assistance under the special supplemental nutrition program for women, infants and children (WIC) under section 17 of the Child Nutrition Act of 1966 (42 U.S.C. 1786); ``(

Summary:

All articles in House section

CHILDREN'S HEALTH ACT OF 2000
(House of Representatives - September 27, 2000)

Text of this article available as: TXT PDF [Pages H8206-H8265] CHILDREN'S HEALTH ACT OF 2000 Ms. PRYCE of Ohio. Mr. Speaker, by direction of the Committee on Rules, I call up House Resolution 594 and ask for its immediate consideration. The Clerk read the resolution, as follows: H. Res. 594 Resolved, That upon adoption of this resolution it shall be in order to take from the [[Page H8207]] Speaker's table the bill (H.R. 4365) to amend the Public Health Service Act with respect to children's health, with Senate amendment thereto, and to consider in the House, without intervention of any point of order, a motion offered by the chairman of the Committee on Commerce or his designee that the House concur in the Senate amendment. The Senate amendment and the motion shall be considered as read. The motion shall be debatable for one hour equally divided and controlled by the chairman and ranking minority member of the Committee on Commerce. The previous question shall be considered as ordered on the motion to final adoption without intervening motion. The SPEAKER pro tempore (Mr. Ose). The gentlewoman from Ohio (Ms. Pryce) is recognized for 1 hour. Ms. PRYCE of Ohio. Mr. Speaker, for the purpose of debate only, I yield the customary 30 minutes to the gentleman from Texas (Mr. Frost); pending which I yield myself such time as I may consume. During consideration of the resolution, all time yielded is for the purpose of debate only. Mr. Speaker, House Resolution 594 is a rule waiving all points of order against a motion to concur in the Senate amendment to H.R. 4365, the Children's Health Act of the year 2000. The rule provides 1 hour of debate on the motion to be equally divided and controlled by the chairman and ranking minority member of the Committee on Commerce. Mr. Speaker, H.R. 4365, the Children's Health Act of 2000, was passed in the House earlier this year on May 9 by a vote of 419 to two. Last week, our colleagues in the other body considered and passed this important legislation with an amendment by unanimous consent. Adoption of this rule and passage of this legislation today is the last step in our work to sending this bill to the President for his signature and thus making this important package a reality. I would like to congratulate the gentleman from Florida (Mr. Bilirakis) and the gentleman from Ohio (Mr. Brown) for their renewed efforts and success on this important legislation and also to commend the gentleman from Virginia (Mr. Bliley), chairman of the Committee on Commerce and the gentleman from Michigan (Mr. Dingell), ranking member, for their hard work and leadership. H.R. 4365, along with the decisions made by the other body, is a comprehensive package of several important children's health bills. Together it addresses a wide variety of critical issues, including day care safety, maternal and infant health, pediatric public health promotion, pediatric research, along with efforts to fight youth drug abuse and provide mental health services. {time} 1030 The legislation includes two important divisions. Division A addresses issues regarding children's health; while Division B focuses on youth drug abuse. Together this package will form the foundation for efforts to address the unique needs of one of our most important constituencies: Our children. The provisions contained in the second part of this legislation, Division D, include a number of provisions previously introduced and considered in the House of Representatives and will allow us to tackle the plague of drug abuse and addiction which are moving through many of our communities. The 1999 National Household Survey on drug abuse reported that some 10.9 percent of our youths, between the ages of 12 and 17, use some form of illicit drug. Just as tragic are the report's findings that alcohol use is also on the rise with our Nation's youth, with some 10.4 million drinkers under the legal age of 21. H.R. 4365 reauthorizes and improves the Substance Abuse and Mental Health Services Administration, SAMSHA, by giving it greater focus on our youth and increased flexibility and accountability for the States. It will provide the needed funds for community-based programs, helping individuals with substance abuse and mental health disorders. It includes the Drug Addiction Treatment Act, introduced by the gentleman from Virginia (Mr. Bliley), to permit qualified physicians to treat their addicted patients and speed up the drug approval process of narcotic drugs needed for additional treatment. Finally, H.R. 4365 includes important provisions to reduce the proliferation of the drug methamphetamine, and tackle the devastating drug currently on the rise with our youth commonly known as Ecstasy. Mr. Speaker, we all hope that the wealth of our Nation and the amazing technological advances that have been made in medicine will give us the necessary resources to protect our children from harm. We have made tremendous progress, but the sad fact is that there are still so many diseases that affect our children for which there is no cure or even an effective treatment. Division A of the legislation before us will give child victims and their families hope by devoting more Federal resources to diseases such as autism, asthma, juvenile diabetes and arthritis. I am especially pleased that this new version of H.R. 4365 includes specific provisions on childhood cancer. By awarding grants, expanding data collection, encouraging uniform reporting standards and urging the national coordination of activities, this bill will go a long way in the battle against this disease that takes the lives of so many of our Nation's children. This legislation also focuses on a new pediatric research initiative at NIH, and reauthorizes money to train physicians at children's hospitals, in order to help us better understand the way in which diseases attack children and how to give them the most effective and appropriate care. There are critical differences between medical care for adults and medical care for children that must be reflected in the training of physicians and treatments designed for a child's system, which is still developing. The children's hospitals across the Nation need funding to adequately train their physicians, and I am so very pleased that H.R. 4365 extends the authorization of appropriations for graduate medical education programs in children's hospitals through fiscal year 2005. This is an issue of fairness, and full authorization is necessary to provide children's hospitals support that is on par with that received by teaching hospitals that care for adults. This legislation recognizes and focuses on these many important differences. Mr. Speaker, while we may never be able to make a child understand why he or she is sick or is made to suffer, we can invest in the research that will allow our best and brightest scientists to solve the mysteries of childhood disease so that more children can have the carefree youths to which they are entitled. What better way to invest our Nation's resources? Mr. Speaker, this measure is straightforward and noncontroversial and its adoption will allow us to complete the work and the business of the House and pass this comprehensive package. I urge all my colleagues to support both the rule and this very important child health initiative. Mr. Speaker, I reserve the balance of my time. Mr. FROST. Mr. Speaker, I yield myself such time as I may consume. As the gentlewoman has explained, this rule will take a Senate amendment from the Speaker's desk and agree to it. Under this procedure, there will be no opportunity to change the bill under consideration with a motion to recommit. Mr. Speaker, 6 years after the Republican majority took control of this House, the Republican leadership has yet to find a way to effectively manage the business of the House. It is 3 days before the end of the fiscal year and 9 days before the Congress is scheduled to end, yet only 2 of the 13 appropriation bills have been sent to the President to be signed; we have yet to consider on this floor the funding bills we need to help people find housing or have safe transportation to get to work or plow their ground to produce food or learn the basic skills to be able to get and hold a job in the modern day workplace. Last night, the members of the Committee on Rules were held hostage for hours past the last vote so that we might be available to bail out the Republican leadership so that the House might have some business to conduct today. Why should the Committee on Rules be held here until 9:30? For one very simple reason, Mr. Speaker. And that is because the majority party still has not figured out how to run this institution in an efficient manner and [[Page H8208]] could not find anything to do on the floor today. However, sometime around 9 p.m. the Republican leadership came up with a solution. So what did they do? The Republican leadership has taken one of the bills that was supposed to be considered yesterday under procedures for noncontroversial bills, suspension of the rules, and moved it to today to be considered under a rule. I do not mean to take anything away from the value of this bill. The Children's Health Act is vitally important to help find new ways to prevent or cure diseases which affect our children. But it should have been passed last night under suspension of the rules, as it was intended to be done. The health organizations, including the March of Dimes, the Spina Bifida Foundation, the Autism Society of America, the Association of Maternal and Child Health Programs, the Epilepsy Foundation, the Cereberal Palsy Association, and many, many others have worked hard to see the bill to completion and were counting on us to do our work. It is past time to get on with this business. Mr. Speaker, I strongly support the Children's Health Act of 2000. This bill now spans 400 pages and has two basic purposes. The first addresses a host of specific childhood health problems and prenatal risk factors, including many provisions which passed in the House earlier this year. The bill authorizes research and public health and health education services that respond to fragile X syndrome, epilepsy, asthma, childhood lead poisoning, pediatric cancers, childhood obesity prevention, traumatic brain injury, juvenile diabetes, hearing loss, oral health, autism, arthritis, muscular dystrophy, autoimmune conditions, child care safety and pediatric organ transplants. It also provides block grants to the States for laboratory infrastructure and patient care services for those affected with or at risk for genetic conditions. The bill contains the first ever authorization of the very successful Healthy Start demonstration project, now in their ninth year of reducing infant mortality and improving pregnancy outcomes in underserved populations. The second feature of this bill covers a wide range of youth drug and mental health service programs that will strengthen America's communities, including extending and reauthorizing programs administered by the Substance Abuse and Mental Health Services Administration. These programs provide critical safety net services for individuals and families with substance abuse problems and mental illness, and also exclusively target youth. It also supports public and professional education programs related to substance abuse and mental illness. The breadth of services provided here range from an underage drinking provision and a suicide prevention initiative, to services for youth offenders, the homeless, and adults with fetal alcohol syndrome. This large and complex bill, however, is marked with a number of procedural irregularities. As worthy as the goals may be, no bill of this scope and magnitude should proceed to the floor without going through the committee process, yet this occurred in the majority's apparent rush to move this bill to the floor. For example, the bill contains a provision that invokes charitable choice. This is a difficult issue for many Members, yet the Committee on the Judiciary was never given the opportunity for public debate on this issue. I know this is of particular concern to my colleague, the gentleman from Virginia (Mr. Scott), who is here to voice his concerns this morning. The second example is marked with some irony. The fine provision promoting safe motherhood includes a public education initiative addressing the dangers of alcohol, tobacco and illicit drug use in pregnancy. Most women do not begin smoking during pregnancy, they begin as adolescents. Yet neither the House nor the Committee on Commerce had the opportunity to even debate the issue of FDA regulation of youth tobacco use during this Congress. I will vote for this bill, however, I want America's children to know that while H.R. 4365 is a measurable step toward improving the quality of their collective health, we can and should do better. It is obvious that this Congress will fail to address many major health care issues that confront us. I am only grateful we have the opportunity to vote for this bill and do something constructive to improve the health care of our Nation's children. Mr. Speaker, I yield 3 minutes to the gentleman from Virginia (Mr. Scott). Mr. SCOTT. Mr. Speaker, I thank the gentleman for yielding me this time, and I rise to oppose the rule because, in its present form, good health care for children now includes a bad crime bill and a provision which waters down our fundamental civil rights. A good child health care bill should not come at such a price. By adopting the rule, we will prohibit amendments to the bill that could fix the methamphetamine drug part of the bill. A similar bill was considered in the Committee on the Judiciary, and amendments could have conformed that 46-page bill to the formal deliberations of the committee. But the rule prohibits amendments, and so the bill now provides new Draconian mandatory minimums for violations of methamphetamines, mandatory minimums that everyone knows do not work. The same mandatory minimums as for crack cocaine. Now, it is interesting that crack cocaine is prevalent in the black community; methamphetamine is more prevalent in the Hispanic community. They get the Draconian mandatory minimums. However, there is an exception to all of this. Ecstasy, which is prevalent in the middle class white community, does not suffer the same mandatory minimums. The Committee on the Judiciary at least had the common decency to make them all equal. But now we have a rule which prohibits any consideration for equalizing this penalty. We have this exemption and, because of the rule, we have to just do it. The rule also protects another form of discrimination: Religious discrimination. Section 3305 has a provision that allows some sponsors of federally funded programs to discriminate on employment based on religion. That is they can tell otherwise qualified individuals that they do not hire their kind because of their religion. These are federally funded programs. We cannot address this discrimination because the rule protects that provision and does not allow any amendments. So if we want good child health care, we have to accept the discrimination; we have to accept the mandatory minimums, with the exception for the middle class white kids. We should not be forced to accept ineffective counterproductive mandatory minimums and religious discrimination as a price for good child health care, and that is why I oppose this rule. Mr. FROST. Mr. Speaker, I yield 2 minutes to the gentleman from New Jersey (Mr. Pascrell). (Mr. PASCRELL asked and was given permission to revise and extend his remarks.) Mr. PASCRELL. Mr. Speaker, I thank the gentleman from Texas for yielding me this time. Mr. Speaker, I am thrilled that the Children's Health Act of 2000 is on the floor today. I would like to thank the Chair of the Subcommittee on Health and the Environment, the gentleman from Florida (Mr. Bilirakis), and the ranking member, the gentleman from Ohio (Mr. Brown), for their leadership and determination to see the bill through. But I want to take special time to salute the gentleman from Pennsylvania (Mr. Greenwood) for his work on behalf of children in America. The gentleman from Pennsylvania has worked tirelessly on behalf of millions of Americans suffering from traumatic brain injury. He has also assisted in my efforts to create the first national traumatic brain injury registry, which is critical. I first became involved with this issue several years ago when a constituent of mine, Dennis Benigno, approached me to tell me about his son, who was struck by a car, hospitalized for months, leaving him with severe cognitive and physical damage. {time} 1045 As a result of his son's accident, Mr. Benigno has been on the front lines researching the disease, informing others, reaching out to the medical research and scientific community, and lobbying elected officials like myself. I am proud of the efforts and the progress my good friend has made on [[Page H8209]] behalf of traumatic brain injury, and I am pleased that the national registry will be included in the Children's Health Act. These brain injury registries will also charge hospitals and local and State departments of health with the task of collecting data for up to a year following the injury. A national registry will help all of us to better understand the injury, what types of treatment people have received, what services they use, and how we can best link people with services. I also hope that we fight each day, like Dennis does, to raise awareness of this disease and to fight for the injured, like his son. I urge all my colleagues to, when the bill comes up after we debate the rule, vote for the passage of this bill. Ms. PRYCE of Ohio. Mr. Speaker, I reserve the balance of my time. Mr. FROST. Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, as I indicated in my opening remarks, this is a good bill. The gentleman from Virginia (Mr. Scott) has some legitimate concerns about a particular matter that he was not able to address. The overall bill is an important piece of legislation. We have concerns on this side that we seem to be treading water here in not being able to bring anything up on the floor on a regular basis. We do not know from day to day what is going to be considered. This bill could have been done on suspension yesterday. That does not diminish the bill. This is an important piece of legislation. I support the bill and support the rule. Mr. Speaker, I yield back the balance of my time. Ms. PRYCE of Ohio. Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, in closing, let me just respond. This very well could have been considered under the suspension calendar last night. We would all have been considering this bill at about 11 p.m. if that were the case. Instead, we chose to come back in the light of day and with everyone well rested and alert and consider this important piece of legislation and allow the American public to hear all the goods things that we are promoting and adopting. In closing, let me remind my colleagues that the House has already passed this with a strong bipartisan support vote of 419-2. Our work today will allow us to dedicate important resources and focus Members on the very unique needs in the health and well-being of our children. I urge adoption of this straightforward, noncontroversial rule and passage of the comprehensive legislation. I applaud my colleagues, the gentleman from Florida (Chairman Bilirakis), and my colleague, the gentleman from Ohio (Mr. Brown), on their hard work. Mr. Speaker, I yield back the balance of my time, and I move the previous question on the resolution. The previous question was ordered. The resolution was agreed to. A motion to reconsider was laid on the table. Mr. BILIRAKIS. Mr. Speaker, pursuant to House Resolution 594, I call up from the Speaker's table the bill (H.R. 4365) to amend the Public Health Service Act with respect to children's health, with the Senate amendment thereto, and ask for its immediate consideration. The Clerk read the title of the bill. Motion Offered by Mr. Bilirakis Mr. BILIRAKIS. Mr. Speaker, I offer a motion. The SPEAKER pro tempore (Mr. Ose). The Clerk will designate the motion. The text of the motion is as follows: Mr. Bilirakis moves that the House concur in the Senate amendment to H.R. 4365, as follows: Senate amendment: Strike out all after the enacting clause and insert: SECTION 1. SHORT TITLE. This Act may be cited as the ``Children's Health Act of 2000''. SEC. 2. TABLE OF CONTENTS. The table of contents for this Act is as follows: Sec. 1. Short title. Sec. 2. Table of contents. DIVISION A--CHILDREN'S HEALTH TITLE I--AUTISM Sec. 101. Expansion, intensification, and coordination of activities of National Institutes of Health with respect to research on autism. Sec. 102. Developmental disabilities surveillance and research programs. Sec. 103. Information and education. Sec. 104. Inter-agency Autism Coordinating Committee. Sec. 105. Report to Congress. TITLE II--RESEARCH AND DEVELOPMENT REGARDING FRAGILE X Sec. 201. National Institute of Child Health and Human Development; research on fragile X. TITLE III--JUVENILE ARTHRITIS AND RELATED CONDITIONS Sec. 301. National Institute of Arthritis and Musculoskeletal and Skin Diseases; research on juvenile arthritis and related conditions. Sec. 302. Information clearinghouse. TITLE IV--REDUCING BURDEN OF DIABETES AMONG CHILDREN AND YOUTH Sec. 401. Programs of Centers for Disease Control and Prevention. Sec. 402. Programs of National Institutes of Health. TITLE V--ASTHMA SERVICES FOR CHILDREN Subtitle A--Asthma Services Sec. 501. Grants for children's asthma relief. Sec. 502. Technical and conforming amendments. Subtitle B--Prevention Activities Sec. 511. Preventive health and health services block grant; systems for reducing asthma-related illnesses through integrated pest management. Subtitle C--Coordination of Federal Activities Sec. 521. Coordination through National Institutes of Health. Subtitle D--Compilation of Data Sec. 531. Compilation of data by Centers for Disease Control and Prevention. TITLE VI--BIRTH DEFECTS PREVENTION ACTIVITIES Subtitle A--Folic Acid Promotion Sec. 601. Program regarding effects of folic acid in prevention of birth defects. Subtitle B--National Center on Birth Defects and Developmental Disabilities Sec. 611. National Center on Birth Defects and Developmental Disabilities. TITLE VII--EARLY DETECTION, DIAGNOSIS, AND TREATMENT REGARDING HEARING LOSS IN INFANTS Sec. 701. Purposes. Sec. 702. Programs of Health Resources and Services Administration, Centers for Disease Control and Prevention, and National Institutes of Health. TITLE VIII--CHILDREN AND EPILEPSY Sec. 801. National public health campaign on epilepsy; seizure disorder demonstration projects in medically underserved areas. TITLE IX--SAFE MOTHERHOOD; INFANT HEALTH PROMOTION Subtitle A--Safe Motherhood Prevention Research Sec. 901. Prevention research and other activities. Subtitle B--Pregnant Women and Infants Health Promotion Sec. 911. Programs regarding prenatal and postnatal health. TITLE X--PEDIATRIC RESEARCH INITIATIVE Sec. 1001. Establishment of pediatric research initiative. Sec. 1002. Investment in tomorrow's pediatric researchers. Sec. 1003. Review of regulations. Sec. 1004. Long-term child development study. TITLE XI--CHILDHOOD MALIGNANCIES Sec. 1101. Programs of Centers for Disease Control and Prevention and National Institutes of Health. TITLE XII--ADOPTION AWARENESS Subtitle A--Infant Adoption Awareness Sec. 1201. Grants regarding infant adoption awareness. Subtitle B--Special Needs Adoption Awareness Sec. 1211. Special needs adoption programs; public awareness campaign and other activities. TITLE XIII--TRAUMATIC BRAIN INJURY Sec. 1301. Programs of Centers for Disease Control and Prevention. Sec. 1302. Study and monitor incidence and prevalence. Sec. 1303. Programs of National Institutes of Health. Sec. 1304. Programs of Health Resources and Services Administration. Sec. 1305. State grants for protection and advocacy services. Sec. 1306. Authorization of appropriations for certain programs. TITLE XIV--CHILD CARE SAFETY AND HEALTH GRANTS Sec. 1401. Definitions. Sec. 1402. Authorization of appropriations. Sec. 1403. Programs. Sec. 1404. Amounts reserved; allotments. Sec. 1405. State applications. Sec. 1406. Use of funds. Sec. 1407. Reports. TITLE XV--HEALTHY START INITIATIVE Sec. 1501. Continuation of healthy start program. [[Page H8210]] TITLE XVI--ORAL HEALTH PROMOTION AND DISEASE PREVENTION Sec. 1601. Identification of interventions that reduce the burden and transmission of oral, dental, and craniofacial diseases in high risk populations; development of approaches for pediatric oral and craniofacial assessment. Sec. 1602. Oral health promotion and disease prevention. Sec. 1603. Coordinated program to improve pediatric oral health. TITLE XVII--VACCINE-RELATED PROGRAMS Subtitle A--Vaccine Compensation Program Sec. 1701. Content of petitions. Subtitle B-- Childhood Immunizations Sec. 1711. Childhood immunizations. TITLE XVIII--HEPATITIS C Sec. 1801. Surveillance and education regarding hepatitis C. TITLE XIX--NIH INITIATIVE ON AUTOIMMUNE DISEASES Sec. 1901. Autoimmune diseases; initiative through Director of National Institutes of Health. TITLE XX--GRADUATE MEDICAL EDUCATION PROGRAMS IN CHILDREN'S HOSPITALS Sec. 2001. Provisions to revise and extend program. TITLE XXI--SPECIAL NEEDS OF CHILDREN REGARDING ORGAN TRANSPLANTATION Sec. 2101. Organ Procurement and Transplantation Network; amendments regarding needs of children. TITLE XXII--MUSCULAR DYSTROPHY RESEARCH Sec. 2201. Muscular dystrophy research. TITLE XXIII--CHILDREN AND TOURETTE SYNDROME AWARENESS Sec. 2301. Grants regarding Tourette Syndrome. TITLE XXIV--CHILDHOOD OBESITY PREVENTION Sec. 2401. Programs operated through the Centers for Disease Control and Prevention. TITLE XXV--EARLY DETECTION AND TREATMENT REGARDING CHILDHOOD LEAD POISONING Sec. 2501. Centers for Disease Control and Prevention efforts to combat childhood lead poisoning. Sec. 2502. Grants for lead poisoning related activities. Sec. 2503. Training and reports by the Health Resources and Services Administration. Sec. 2504. Screenings, referrals, and education regarding lead poisoning. TITLE XXVI--SCREENING FOR HERITABLE DISORDERS Sec. 2601. Program to improve the ability of States to provide newborn and child screening for heritable disorders. TITLE XXVII--PEDIATRIC RESEARCH PROTECTIONS Sec. 2701. Requirement for additional protections for children involved in research. TITLE XXVIII--MISCELLANEOUS PROVISIONS Sec. 2801. Report regarding research on rare diseases in children. Sec. 2802. Study on metabolic disorders. TITLE XXIX--EFFECTIVE DATE Sec. 2901. Effective date. DIVISION B--YOUTH DRUG AND MENTAL HEALTH SERVICES Sec. 3001. Short title. TITLE XXXI--PROVISIONS RELATING TO SERVICES FOR CHILDREN AND ADOLESCENTS Sec. 3101. Children and violence. Sec. 3102. Emergency response. Sec. 3103. High risk youth reauthorization. Sec. 3104. Substance abuse treatment services for children and adolescents. Sec. 3105. Comprehensive community services for children with serious emotional disturbance. Sec. 3106. Services for children of substance abusers. Sec. 3107. Services for youth offenders. Sec. 3108. Grants for strengthening families through community partnerships. Sec. 3109. Programs to reduce underage drinking. Sec. 3110. Services for individuals with fetal alcohol syndrome. Sec. 3111. Suicide prevention. Sec. 3112. General provisions. TITLE XXXII--PROVISIONS RELATING TO MENTAL HEALTH Sec. 3201. Priority mental health needs of regional and national significance. Sec. 3202. Grants for the benefit of homeless individuals. Sec. 3203. Projects for assistance in transition from homelessness. Sec. 3204. Community mental health services performance partnership block grant. Sec. 3205. Determination of allotment. Sec. 3206. Protection and Advocacy for Mentally Ill Individuals Act of 1986. Sec. 3207. Requirement relating to the rights of residents of certain facilities. Sec. 3208. Requirement relating to the rights of residents of certain non-medical, community-based facilities for children and youth. Sec. 3209. Emergency mental health centers. Sec. 3210. Grants for jail diversion programs. Sec. 3211. Improving outcomes for children and adolescents through services integration between child welfare and mental health services. Sec. 3212. Grants for the integrated treatment of serious mental illness and co-occurring substance abuse. Sec. 3213. Training grants. TITLE XXXIII--PROVISIONS RELATING TO SUBSTANCE ABUSE Sec. 3301. Priority substance abuse treatment needs of regional and national significance. Sec. 3302. Priority substance abuse prevention needs of regional and national significance. Sec. 3303. Substance abuse prevention and treatment performance partnership block grant. Sec. 3304. Determination of allotments. Sec. 3305. Nondiscrimination and institutional safeguards for religious providers. Sec. 3306. Alcohol and drug prevention or treatment services for Indians and Native Alaskans. Sec. 3307. Establishment of commission. TITLE XXXIV--PROVISIONS RELATING TO FLEXIBILITY AND ACCOUNTABILITY Sec. 3401. General authorities and peer review. Sec. 3402. Advisory councils. Sec. 3403. General provisions for the performance partnership block grants. Sec. 3404. Data infrastructure projects. Sec. 3405. Repeal of obsolete addict referral provisions. Sec. 3406. Individuals with co-occurring disorders. Sec. 3407. Services for individuals with co-occurring disorders. TITLE XXXV--WAIVER AUTHORITY FOR PHYSICIANS WHO DISPENSE OR PRESCRIBE CERTAIN NARCOTIC DRUGS FOR MAINTENANCE TREATMENT OR DETOXIFICATION TREATMENT Sec. 3501. Short title. Sec. 3502. Amendment to Controlled Substances Act. TITLE XXXVI--METHAMPHETAMINE AND OTHER CONTROLLED SUBSTANCES Sec. 3601. Short title. Subtitle A--Methamphetamine Production, Trafficking, and Abuse Part I--Criminal Penalties Sec. 3611. Enhanced punishment of amphetamine laboratory operators. Sec. 3612. Enhanced punishment of amphetamine or methamphetamine laboratory operators. Sec. 3613. Mandatory restitution for violations of Controlled Substances Act and Controlled Substances Import and Export Act relating to amphetamine and methamphetamine. Sec. 3614. Methamphetamine paraphernalia. Part II--Enhanced Law Enforcement Sec. 3621. Environmental hazards associated with illegal manufacture of amphetamine and methamphetamine. Sec. 3622. Reduction in retail sales transaction threshold for non-safe harbor products containing pseudoephedrine or phenylpropanolamine. Sec. 3623. Training for Drug Enforcement Administration and State and local law enforcement personnel relating to clandestine laboratories. Sec. 3624. Combating methamphetamine and amphetamine in high intensity drug trafficking areas. Sec. 3625. Combating amphetamine and methamphetamine manufacturing and trafficking. Part III--Abuse Prevention and Treatment Sec. 3631. Expansion of methamphetamine research. Sec. 3632. Methamphetamine and amphetamine treatment initiative by Center for Substance Abuse Treatment. Sec. 3633. Study of methamphetamine treatment. Part IV--Reports Sec. 3641. Reports on consumption of methamphetamine and other illicit drugs in rural areas, metropolitan areas, and consolidated metropolitan areas. Sec. 3642. Report on diversion of ordinary, over-the-counter pseudoephedrine and phenylpropanolamine products. Subtitle B--Controlled Substances Generally Sec. 3651. Enhanced punishment for trafficking in list I chemicals. Sec. 3652. Mail order requirements. Sec. 3653. Theft and transportation of anhydrous ammonia for purposes of illicit production of controlled substances. Subtitle C--Ecstasy Anti-Proliferation Act of 2000 Sec. 3661. Short title. Sec. 3662. Findings. Sec. 3663. Enhanced punishment of Ecstasy traffickers. Sec. 3664. Emergency authority to United States Sentencing Commission. Sec. 3665. Expansion of Ecstasy and club drugs abuse prevention efforts. Subtitle D--Miscellaneous Sec. 3671. Antidrug messages on Federal Government Internet websites. Sec. 3672. Reimbursement by Drug Enforcement Administration of expenses incurred to remediate methamphetamine laboratories. Sec. 3673. Severability. [[Page H8211]] DIVISION A--CHILDREN'S HEALTH TITLE I--AUTISM SEC. 101. EXPANSION, INTENSIFICATION, AND COORDINATION OF ACTIVITIES OF NATIONAL INSTITUTES OF HEALTH WITH RESPECT TO RESEARCH ON AUTISM. Part B of title IV of the Public Health Service Act (42 U.S.C. 284 et seq.) is amended by adding at the end the following section: ``expansion, intensification, and coordination of activities of national institutes of health with respect to research on autism ``Sec. 409C. (a) In General.-- ``(1) Expansion of activities.--The Director of NIH (in this section referred to as the `Director') shall expand, intensify, and coordinate the activities of the National Institutes of Health with respect to research on autism. ``(2) Administration of program; collaboration among agencies.--The Director shall carry out this section acting through the Director of the National Institute of Mental Health and in collaboration with any other agencies that the Director determines appropriate. ``(b) Centers of Excellence.-- ``(1) In general.--The Director shall under subsection (a)(1) make awards of grants and contracts to public or nonprofit private entities to pay all or part of the cost of planning, establishing, improving, and providing basic operating support for centers of excellence regarding research on autism. ``(2) Research.--Each center under paragraph (1) shall conduct basic and clinical research into autism. Such research should include investigations into the cause, diagnosis, early detection, prevention, control, and treatment of autism. The centers, as a group, shall conduct research including the fields of developmental neurobiology, genetics, and psychopharmacology. ``(3) Services for patients.-- ``(A) In general.--A center under paragraph (1) may expend amounts provided under such paragraph to carry out a program to make individuals aware of opportunities to participate as subjects in research conducted by the centers. ``(B) Referrals and costs.--A program under subparagraph (A) may, in accordance with such criteria as the Director may establish, provide to the subjects described in such subparagraph, referrals for health and other services, and such patient care costs as are required for research. ``(C) Availability and access.--The extent to which a center can demonstrate availability and access to clinical services shall be considered by the Director in decisions about awarding grants to applicants which meet the scientific criteria for funding under this section. ``(4) Coordination of centers; reports.--The Director shall, as appropriate, provide for the coordination of information among centers under paragraph (1) and ensure regular communication between such centers, and may require the periodic preparation of reports on the activities of the centers and the submission of the reports to the Director. ``(5) Organization of centers.--Each center under paragraph (1) shall use the facilities of a single institution, or be formed from a consortium of cooperating institutions, meeting such requirements as may be prescribed by the Director. ``(6) Number of centers; duration of support.-- ``(A) In general.--The Director shall provide for the establishment of not less than 5 centers under paragraph (1). ``(B) Duration.--Support for a center established under paragraph (1) may be provided under this section for a period of not to exceed 5 years. Such period may be extended for 1 or more additional periods not exceeding 5 years if the operations of such center have been reviewed by an appropriate technical and scientific peer review group established by the Director and if such group has recommended to the Director that such period should be extended. ``(c) Facilitation of Research.--The Director shall under subsection (a)(1) provide for a program under which samples of tissues and genetic materials that are of use in research on autism are donated, collected, preserved, and made available for such research. The program shall be carried out in accordance with accepted scientific and medical standards for the donation, collection, and preservation of such samples. ``(d) Public Input.--The Director shall under subsection (a)(1) provide for means through which the public can obtain information on the existing and planned programs and activities of the National Institutes of Health with respect to autism and through which the Director can receive comments from the public regarding such programs and activities. ``(e) Funding.--There are authorized to be appropriated such sums as may be necessary to carry out this section. Amounts appropriated under this subsection are in addition to any other amounts appropriated for such purpose.''. SEC. 102. DEVELOPMENTAL DISABILITIES SURVEILLANCE AND RESEARCH PROGRAMS. (a) National Autism and Pervasive Developmental Disabilities Surveillance Program.-- (1) In general.--The Secretary of Health and Human Services (in this section referred to as the ``Secretary''), acting through the Director of the Centers for Disease Control and Prevention, may make awards of grants and cooperative agreements for the collection, analysis, and reporting of data on autism and pervasive developmental disabilities. In making such awards, the Secretary may provide direct technical assistance in lieu of cash. (2) Eligibility.--To be eligible to receive an award under paragraph (1) an entity shall be a public or nonprofit private entity (including health departments of States and political subdivisions of States, and including universities and other educational entities). (b) Centers of Excellence in Autism and Pervasive Developmental Disabilities Epidemiology.-- (1) In general.--The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall establish not less than 3 regional centers of excellence in autism and pervasive developmental disabilities epidemiology for the purpose of collecting and analyzing information on the number, incidence, correlates, and causes of autism and related developmental disabilities. (2) Recipients of awards for establishment of centers.-- Centers under paragraph (1) shall be established and operated through the awarding of grants or cooperative agreements to public or nonprofit private entities that conduct research, including health departments of States and political subdivisions of States, and including universities and other educational entities. (3) Certain requirements.--An award for a center under paragraph (1) may be made only if the entity involved submits to the Secretary an application containing such agreements and information as the Secretary may require, including an agreement that the center involved will operate in accordance with the following: (A) The center will collect, analyze, and report autism and pervasive developmental disabilities data according to guidelines prescribed by the Director, after consultation with relevant State and local public health officials, private sector developmental disability researchers, and advocates for those with developmental disabilities. (B) The center will assist with the development and coordination of State autism and pervasive developmental disabilities surveillance efforts within a region. (C) The center will identify eligible cases and controls through its surveillance systems and conduct research into factors which may cause autism and related developmental disabilities. (D) The center will develop or extend an area of special research expertise (including genetics, environmental exposure to contaminants, immunology, and other relevant research specialty areas). (c) Clearinghouse.--The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall carry out the following: (1) The Secretary shall establish a clearinghouse within the Centers for Disease Control and Prevention for the collection and storage of data generated from the monitoring programs established by this title. Through the clearinghouse, such Centers shall serve as the coordinating agency for autism and pervasive developmental disabilities surveillance activities. The functions of such a clearinghouse shall include facilitating the coordination of research and policy development relating to the epidemiology of autism and other pervasive developmental disabilities. (2) The Secretary shall coordinate the Federal response to requests for assistance from State health department officials regarding potential or alleged autism or developmental disability clusters. (d) Definition.--In this title, the term ``State'' means each of the several States, the District of Columbia, the Commonwealth of Puerto Rico, American Samoa, Guam, the Commonwealth of the Northern Mariana Islands, the Virgin Islands, and the Trust Territory of the Pacific Islands. (e) Authorization of Appropriations.--There are authorized to be appropriated such sums as may be necessary to carry out this section. SEC. 103. INFORMATION AND EDUCATION. (a) In General.--The Secretary shall establish and implement a program to provide information and education on autism to health professionals and the general public, including information and education on advances in the diagnosis and treatment of autism and training and continuing education through programs for scientists, physicians, and other health professionals who provide care for patients with autism. (b) Stipends.--The Secretary may use amounts made available under this section to provide stipends for health professionals who are enrolled in training programs under this section. (c) Authorization of Appropriations.--There are authorized to be appropriated such sums as may be necessary to carry out this section. SEC. 104. INTER-AGENCY AUTISM COORDINATING COMMITTEE. (a) Establishment.--The Secretary shall establish a committee to be known as the ``Autism Coordinating Committee'' (in this section referred to as the ``Committee'') to coordinate all efforts within the Department of Health and Human Services concerning autism, including activities carried out through the National Institutes of Health and the Centers for Disease Control and Prevention under this title (and the amendment made by this title). (b) Membership.-- (1) In general.--The Committee shall be composed of the Directors of such national research institutes, of the Centers for Disease Control and Prevention, and of such other agencies and such other officials as the Secretary determines appropriate. (2) Additional members.--If determined appropriate by the Secretary, the Secretary may appoint to the Committee-- (A) parents or legal guardians of individuals with autism or other pervasive developmental disorders; and [[Page H8212]] (B) representatives of other governmental agencies that serve children with autism such as the Department of Education. (c) Administrative Support; Terms of Service; Other Provisions.--The following shall apply with respect to the Committee: (1) The Committee shall receive necessary and appropriate administrative support from the Department of Health and Human Services. (2) Members of the Committee appointed under subsection (b)(2)(A) shall serve for a term of 3 years, and may serve for an unlimited number of terms if reappointed. (3) The Committee shall meet not less than 2 times each year. SEC. 105. REPORT TO CONGRESS. Not later than January 1, 2001, and each January 1 thereafter, the Secretary shall prepare and submit to the appropriate committees of Congress, a report concerning the implementation of this title and the amendments made by this title. TITLE II--RESEARCH AND DEVELOPMENT REGARDING FRAGILE X SEC. 201. NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT; RESEARCH ON FRAGILE X. Subpart 7 of part C of title IV of the Public Health Service Act is amended by adding at the end the following section: ``fragile x ``Sec. 452E. (a) Expansion and Coordination of Research Activities.--The Director of the Institute, after consultation with the advisory council for the Institute, shall expand, intensify, and coordinate the activities of the Institute with respect to research on the disease known as fragile X. ``(b) Research Centers.-- ``(1) In general.--The Director of the Institute shall make grants or enter into contracts for the development and operation of centers to conduct research for the purposes of improving the diagnosis and treatment of, and finding the cure for, fragile X. ``(2) Number of centers.-- ``(A) In general.--In carrying out paragraph (1), the Director of the Institute shall, to the extent that amounts are appropriated, and subject to subparagraph (B), provide for the establishment of at least three fragile X research centers. ``(B) Peer review requirement.--The Director of the Institute shall make a grant to, or enter into a contract with, an entity for purposes of establishing a center under paragraph (1) only if the grant or contract has been recommended after technical and scientific peer review required by regulations under section 492. ``(3) Activities.--The Director of the Institute, with the assistance of centers established under paragraph (1), shall conduct and support basic and biomedical research into the detection and treatment of fragile X. ``(4) Coordination among centers.--The Director of the Institute shall, as appropriate, provide for the coordination of the activities of the centers assisted under this section, including providing for the exchange of information among the centers. ``(5) Certain administrative requirements.--Each center assisted under paragraph (1) shall use the facilities of a single institution, or be formed from a consortium of cooperating institutions, meeting such requirements as may be prescribed by the Director of the Institute. ``(6) Duration of support.--Support may be provided to a center under paragraph (1) for a period not exceeding 5 years. Such period may be extended for one or more additional periods, each of which may not exceed 5 years, if the operations of such center have been reviewed by an appropriate technical and scientific peer review group established by the Director and if such group has recommended to the Director that such period be extended. ``(7) Authorization of appropriations.--For the purpose of carrying out this subsection, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2001 through 2005.''. TITLE III--JUVENILE ARTHRITIS AND RELATED CONDITIONS SEC. 301. NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES; RESEARCH ON JUVENILE ARTHRITIS AND RELATED CONDITIONS. (a) In General.--Subpart 4 of part C of title IV of the Public Health Service Act (42 U.S.C. 285d et seq.) is amended by inserting after section 442 the following section: ``juvenile arthritis and related conditions ``Sec. 442A. (a) Expansion and Coordination of Activities.--The Director of the Institute, in coordination with the Director of the National Institute of Allergy and Infectious Diseases, shall expand and intensify the programs of such Institutes with respect to research and related activities concerning juvenile arthritis and related conditions. ``(b) Coordination.--The Directors referred to in subsection (a) shall jointly coordinate the programs referred to in such subsection and consult with the Arthritis and Musculoskeletal Diseases Interagency Coordinating Committee. ``(c) Authorization of Appropriations.--For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2001 through 2005.''. (b) Pediatric Rheumatology.--Subpart 1 of part E of title VII of the Public Health Service Act (42 U.S.C. 294n et seq.) is amended by adding at the end the following: ``SEC. 763. PEDIATRIC RHEUMATOLOGY. ``(a) In General.--The Secretary, acting through the appropriate agencies, shall evaluate whether the number of pediatric rheumatologists is sufficient to address the health care needs of children with arthritis and related conditions, and if the Secretary determines that the number is not sufficient, shall develop strategies to help address the shortfall. ``(b) Report to Congress.--Not later than October 1, 2001, the Secretary shall submit to the Congress a report describing the results of the evaluation under subsection (a), and as applicable, the strategies developed under such subsection. ``(c) Authorization of Appropriations.--For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2001 through 2005.''. SEC. 302. INFORMATION CLEARINGHOUSE. Section 438(b) of the Public Health Service Act (42 U.S.C. 285d-3(b)) is amended by inserting ``, including juvenile arthritis and related conditions,'' after ``diseases''. TITLE IV--REDUCING BURDEN OF DIABETES AMONG CHILDREN AND YOUTH SEC. 401. PROGRAMS OF CENTERS FOR DISEASE CONTROL AND PREVENTION. Part B of title III of the Public Health Service Act (42 U.S.C. 243 et seq.) is amended by inserting after section 317G the following section: ``diabetes in children and youth ``Sec. 317H. (a) Surveillance on Juvenile Diabetes.--The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall develop a sentinel system to collect data on juvenile diabetes, including with respect to incidence and prevalence, and shall establish a national database for such data. ``(b) Type 2 Diabetes in Youth.--The Secretary shall implement a national public health effort to address type 2 diabetes in youth, including-- ``(1) enhancing surveillance systems and expanding research to better assess the prevalence and incidence of type 2 diabetes in youth and determine the extent to which type 2 diabetes is incorrectly diagnosed as type 1 diabetes among children; and ``(2) developing and improving laboratory methods to assist in diagnosis, treatment, and prevention of diabetes including, but not limited to, developing noninvasive ways to monitor blood glucose to prevent hypoglycemia and improving existing glucometers that measure blood glucose. ``(c) Authorization of Appropriations.--For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2001 through 2005.''. SEC. 402. PROGRAMS OF NATIONAL INSTITUTES OF HEALTH. Subpart 3 of part C of title IV of the Public Health Service Act (42 U.S.C. 285c et seq.) is amended by inserting after section 434 the following section: ``juvenile diabetes ``Sec. 434A. (a) Long-Term Epidemiology Studies.--The Director of the Institute shall conduct or support long-term epidemiology studies in which individuals with or at risk for type 1, or juvenile, diabetes are followed for 10 years or more. Such studies shall investigate the causes and characteristics of the disease and its complications. ``(b) Clinical Trial Infrastructure/Innovative Treatments for Juvenile Diabetes.--The Secretary, acting through the Director of the National Institutes of Health, shall support regional clinical research centers for the prevention, detection, treatment, and cure of juvenile diabetes. ``(c) Prevention of Type 1 Diabetes.--The Secretary, acting through the appropriate agencies, shall provide for a national effort to prevent type 1 diabetes. Such effort shall provide for a combination of increased efforts in research and development of prevention strategies, including consideration of vaccine development, coupled with appropriate ability to test the effectiveness of such strategies in large clinical trials of children and young adults. ``(d) Authorization of Appropriations.--For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2001 through 2005.''. TITLE V--ASTHMA SERVICES FOR CHILDREN Subtitle A--Asthma Services SEC. 501. GRANTS FOR CHILDREN'S ASTHMA RELIEF. Title III of the Public Health Service Act (42 U.S.C. 241 et seq.) is amended by adding at the end the following part: ``PART P--ADDITIONAL PROGRAMS ``SEC. 399L. CHILDREN'S ASTHMA TREATMENT GRANTS PROGRAM. ``(a) Authority To Make Grants.-- ``(1) In general.--In addition to any other payments made under this Act or title V of the Social Security Act, the Secretary shall award grants to eligible entities to carry out the following purposes: ``(A) To provide access to quality medical care for children who live in areas that have a high prevalence of asthma and who lack access to medical care. ``(B) To provide on-site education to parents, children, health care providers, and medical teams to recognize the signs and symptoms of asthma, and to train them in the use of medications to treat asthma and prevent its exacerbations. ``(C) To decrease preventable trips to the emergency room by making medication available to individuals who have not previously had access to treatment or education in the management of asthma. ``(D) To provide other services, such as smoking cessation programs, home modification, and other direct and support services that ameliorate conditions that exacerbate or induce asthma. ``(2) Certain projects.--In making grants under paragraph (1), the Secretary may make [[Page H8213]] grants designed to develop and expand the following projects: ``(A) Projects to provide comprehensive asthma services to children in accordance with the guidelines of the National Asthma Education and Prevention Program (through the National Heart, Lung and Blood Institute), including access to care and treatment for asthma in a community-based setting. ``(B) Projects to fully equip mobile health care clinics that provide preventive asthma care including diagnosis, physical examinations, pharmacological therapy, skin testing, peak flow meter testing, and other asthma-related health care services. ``(C) Projects to conduct validated asthma management education programs for patients with asthma and their families, including patient education regarding asthma management, family education on asthma management, and the distribution of materials, including displays and videos, to reinforce concepts presented by medical teams. ``(2) Award of grants.-- ``(A) Application.-- ``(i) In general.--An eligible entity shall submit an application to the Secretary for a grant under this section in such form and manner as the Secretary may require. ``(ii) Required information.--An application submitted under this subparagraph shall include a plan for the use of funds awarded under the grant and such other information as the Secretary may require. ``(B) Requirement.--In awarding grants under this section, the Secretary shall give preference to eligible entities that demonstrate that the activities to be carried out under this section shall be in localities within areas of known or suspected high prevalence of childhood asthma or high asthma- related mortality or high rate of hospitalization or emergency room visits for asthma (relative to the average asthma prevalence rates and associated mortality rates in the United States). Acceptable data sets to demonstrate a high prevalence of childhood asthma or high asthma-related mortality may include data from Federal, State, or local vital statistics, claims data under title XIX or XXI of the Social Security Act, other public health statistics or surveys, or other data that the Secretary, in consultation with the Director of the Centers for Disease Control and Prevention, deems appropriate. ``(3) Definition of eligible entity.--For purposes of this section, the term `eligible entity' means a public or nonprofit private entity (including a State or political subdivision of a State), or a consortium of any of such entities. ``(b) Coordination With Other Children's Programs.--An eligible entity shall identify in the plan submitted as part of an application for a grant under this section how the entity will coordinate operations and activities under the grant with-- ``(1) other programs operated in the State that serve children with asthma, including any such programs operated under titles V, XIX, or XXI of the Social Security Act; and ``(2) one or more of the following-- ``(A) the child welfare and foster care and adoption assistance programs under parts B and E of title IV of such Act; ``(B) the head start program established under the Head Start Act (42 U.S.C. 9831 et seq.); ``(C) the program of assistance under the special supplemental nutrition program for women, infants and children (WIC) under section 17 of the Child Nutrition Act of 1966 (42 U.S.C. 1786); ``(D) local p

Major Actions:

All articles in House section

CHILDREN'S HEALTH ACT OF 2000
(House of Representatives - September 27, 2000)

Text of this article available as: TXT PDF [Pages H8206-H8265] CHILDREN'S HEALTH ACT OF 2000 Ms. PRYCE of Ohio. Mr. Speaker, by direction of the Committee on Rules, I call up House Resolution 594 and ask for its immediate consideration. The Clerk read the resolution, as follows: H. Res. 594 Resolved, That upon adoption of this resolution it shall be in order to take from the [[Page H8207]] Speaker's table the bill (H.R. 4365) to amend the Public Health Service Act with respect to children's health, with Senate amendment thereto, and to consider in the House, without intervention of any point of order, a motion offered by the chairman of the Committee on Commerce or his designee that the House concur in the Senate amendment. The Senate amendment and the motion shall be considered as read. The motion shall be debatable for one hour equally divided and controlled by the chairman and ranking minority member of the Committee on Commerce. The previous question shall be considered as ordered on the motion to final adoption without intervening motion. The SPEAKER pro tempore (Mr. Ose). The gentlewoman from Ohio (Ms. Pryce) is recognized for 1 hour. Ms. PRYCE of Ohio. Mr. Speaker, for the purpose of debate only, I yield the customary 30 minutes to the gentleman from Texas (Mr. Frost); pending which I yield myself such time as I may consume. During consideration of the resolution, all time yielded is for the purpose of debate only. Mr. Speaker, House Resolution 594 is a rule waiving all points of order against a motion to concur in the Senate amendment to H.R. 4365, the Children's Health Act of the year 2000. The rule provides 1 hour of debate on the motion to be equally divided and controlled by the chairman and ranking minority member of the Committee on Commerce. Mr. Speaker, H.R. 4365, the Children's Health Act of 2000, was passed in the House earlier this year on May 9 by a vote of 419 to two. Last week, our colleagues in the other body considered and passed this important legislation with an amendment by unanimous consent. Adoption of this rule and passage of this legislation today is the last step in our work to sending this bill to the President for his signature and thus making this important package a reality. I would like to congratulate the gentleman from Florida (Mr. Bilirakis) and the gentleman from Ohio (Mr. Brown) for their renewed efforts and success on this important legislation and also to commend the gentleman from Virginia (Mr. Bliley), chairman of the Committee on Commerce and the gentleman from Michigan (Mr. Dingell), ranking member, for their hard work and leadership. H.R. 4365, along with the decisions made by the other body, is a comprehensive package of several important children's health bills. Together it addresses a wide variety of critical issues, including day care safety, maternal and infant health, pediatric public health promotion, pediatric research, along with efforts to fight youth drug abuse and provide mental health services. {time} 1030 The legislation includes two important divisions. Division A addresses issues regarding children's health; while Division B focuses on youth drug abuse. Together this package will form the foundation for efforts to address the unique needs of one of our most important constituencies: Our children. The provisions contained in the second part of this legislation, Division D, include a number of provisions previously introduced and considered in the House of Representatives and will allow us to tackle the plague of drug abuse and addiction which are moving through many of our communities. The 1999 National Household Survey on drug abuse reported that some 10.9 percent of our youths, between the ages of 12 and 17, use some form of illicit drug. Just as tragic are the report's findings that alcohol use is also on the rise with our Nation's youth, with some 10.4 million drinkers under the legal age of 21. H.R. 4365 reauthorizes and improves the Substance Abuse and Mental Health Services Administration, SAMSHA, by giving it greater focus on our youth and increased flexibility and accountability for the States. It will provide the needed funds for community-based programs, helping individuals with substance abuse and mental health disorders. It includes the Drug Addiction Treatment Act, introduced by the gentleman from Virginia (Mr. Bliley), to permit qualified physicians to treat their addicted patients and speed up the drug approval process of narcotic drugs needed for additional treatment. Finally, H.R. 4365 includes important provisions to reduce the proliferation of the drug methamphetamine, and tackle the devastating drug currently on the rise with our youth commonly known as Ecstasy. Mr. Speaker, we all hope that the wealth of our Nation and the amazing technological advances that have been made in medicine will give us the necessary resources to protect our children from harm. We have made tremendous progress, but the sad fact is that there are still so many diseases that affect our children for which there is no cure or even an effective treatment. Division A of the legislation before us will give child victims and their families hope by devoting more Federal resources to diseases such as autism, asthma, juvenile diabetes and arthritis. I am especially pleased that this new version of H.R. 4365 includes specific provisions on childhood cancer. By awarding grants, expanding data collection, encouraging uniform reporting standards and urging the national coordination of activities, this bill will go a long way in the battle against this disease that takes the lives of so many of our Nation's children. This legislation also focuses on a new pediatric research initiative at NIH, and reauthorizes money to train physicians at children's hospitals, in order to help us better understand the way in which diseases attack children and how to give them the most effective and appropriate care. There are critical differences between medical care for adults and medical care for children that must be reflected in the training of physicians and treatments designed for a child's system, which is still developing. The children's hospitals across the Nation need funding to adequately train their physicians, and I am so very pleased that H.R. 4365 extends the authorization of appropriations for graduate medical education programs in children's hospitals through fiscal year 2005. This is an issue of fairness, and full authorization is necessary to provide children's hospitals support that is on par with that received by teaching hospitals that care for adults. This legislation recognizes and focuses on these many important differences. Mr. Speaker, while we may never be able to make a child understand why he or she is sick or is made to suffer, we can invest in the research that will allow our best and brightest scientists to solve the mysteries of childhood disease so that more children can have the carefree youths to which they are entitled. What better way to invest our Nation's resources? Mr. Speaker, this measure is straightforward and noncontroversial and its adoption will allow us to complete the work and the business of the House and pass this comprehensive package. I urge all my colleagues to support both the rule and this very important child health initiative. Mr. Speaker, I reserve the balance of my time. Mr. FROST. Mr. Speaker, I yield myself such time as I may consume. As the gentlewoman has explained, this rule will take a Senate amendment from the Speaker's desk and agree to it. Under this procedure, there will be no opportunity to change the bill under consideration with a motion to recommit. Mr. Speaker, 6 years after the Republican majority took control of this House, the Republican leadership has yet to find a way to effectively manage the business of the House. It is 3 days before the end of the fiscal year and 9 days before the Congress is scheduled to end, yet only 2 of the 13 appropriation bills have been sent to the President to be signed; we have yet to consider on this floor the funding bills we need to help people find housing or have safe transportation to get to work or plow their ground to produce food or learn the basic skills to be able to get and hold a job in the modern day workplace. Last night, the members of the Committee on Rules were held hostage for hours past the last vote so that we might be available to bail out the Republican leadership so that the House might have some business to conduct today. Why should the Committee on Rules be held here until 9:30? For one very simple reason, Mr. Speaker. And that is because the majority party still has not figured out how to run this institution in an efficient manner and [[Page H8208]] could not find anything to do on the floor today. However, sometime around 9 p.m. the Republican leadership came up with a solution. So what did they do? The Republican leadership has taken one of the bills that was supposed to be considered yesterday under procedures for noncontroversial bills, suspension of the rules, and moved it to today to be considered under a rule. I do not mean to take anything away from the value of this bill. The Children's Health Act is vitally important to help find new ways to prevent or cure diseases which affect our children. But it should have been passed last night under suspension of the rules, as it was intended to be done. The health organizations, including the March of Dimes, the Spina Bifida Foundation, the Autism Society of America, the Association of Maternal and Child Health Programs, the Epilepsy Foundation, the Cereberal Palsy Association, and many, many others have worked hard to see the bill to completion and were counting on us to do our work. It is past time to get on with this business. Mr. Speaker, I strongly support the Children's Health Act of 2000. This bill now spans 400 pages and has two basic purposes. The first addresses a host of specific childhood health problems and prenatal risk factors, including many provisions which passed in the House earlier this year. The bill authorizes research and public health and health education services that respond to fragile X syndrome, epilepsy, asthma, childhood lead poisoning, pediatric cancers, childhood obesity prevention, traumatic brain injury, juvenile diabetes, hearing loss, oral health, autism, arthritis, muscular dystrophy, autoimmune conditions, child care safety and pediatric organ transplants. It also provides block grants to the States for laboratory infrastructure and patient care services for those affected with or at risk for genetic conditions. The bill contains the first ever authorization of the very successful Healthy Start demonstration project, now in their ninth year of reducing infant mortality and improving pregnancy outcomes in underserved populations. The second feature of this bill covers a wide range of youth drug and mental health service programs that will strengthen America's communities, including extending and reauthorizing programs administered by the Substance Abuse and Mental Health Services Administration. These programs provide critical safety net services for individuals and families with substance abuse problems and mental illness, and also exclusively target youth. It also supports public and professional education programs related to substance abuse and mental illness. The breadth of services provided here range from an underage drinking provision and a suicide prevention initiative, to services for youth offenders, the homeless, and adults with fetal alcohol syndrome. This large and complex bill, however, is marked with a number of procedural irregularities. As worthy as the goals may be, no bill of this scope and magnitude should proceed to the floor without going through the committee process, yet this occurred in the majority's apparent rush to move this bill to the floor. For example, the bill contains a provision that invokes charitable choice. This is a difficult issue for many Members, yet the Committee on the Judiciary was never given the opportunity for public debate on this issue. I know this is of particular concern to my colleague, the gentleman from Virginia (Mr. Scott), who is here to voice his concerns this morning. The second example is marked with some irony. The fine provision promoting safe motherhood includes a public education initiative addressing the dangers of alcohol, tobacco and illicit drug use in pregnancy. Most women do not begin smoking during pregnancy, they begin as adolescents. Yet neither the House nor the Committee on Commerce had the opportunity to even debate the issue of FDA regulation of youth tobacco use during this Congress. I will vote for this bill, however, I want America's children to know that while H.R. 4365 is a measurable step toward improving the quality of their collective health, we can and should do better. It is obvious that this Congress will fail to address many major health care issues that confront us. I am only grateful we have the opportunity to vote for this bill and do something constructive to improve the health care of our Nation's children. Mr. Speaker, I yield 3 minutes to the gentleman from Virginia (Mr. Scott). Mr. SCOTT. Mr. Speaker, I thank the gentleman for yielding me this time, and I rise to oppose the rule because, in its present form, good health care for children now includes a bad crime bill and a provision which waters down our fundamental civil rights. A good child health care bill should not come at such a price. By adopting the rule, we will prohibit amendments to the bill that could fix the methamphetamine drug part of the bill. A similar bill was considered in the Committee on the Judiciary, and amendments could have conformed that 46-page bill to the formal deliberations of the committee. But the rule prohibits amendments, and so the bill now provides new Draconian mandatory minimums for violations of methamphetamines, mandatory minimums that everyone knows do not work. The same mandatory minimums as for crack cocaine. Now, it is interesting that crack cocaine is prevalent in the black community; methamphetamine is more prevalent in the Hispanic community. They get the Draconian mandatory minimums. However, there is an exception to all of this. Ecstasy, which is prevalent in the middle class white community, does not suffer the same mandatory minimums. The Committee on the Judiciary at least had the common decency to make them all equal. But now we have a rule which prohibits any consideration for equalizing this penalty. We have this exemption and, because of the rule, we have to just do it. The rule also protects another form of discrimination: Religious discrimination. Section 3305 has a provision that allows some sponsors of federally funded programs to discriminate on employment based on religion. That is they can tell otherwise qualified individuals that they do not hire their kind because of their religion. These are federally funded programs. We cannot address this discrimination because the rule protects that provision and does not allow any amendments. So if we want good child health care, we have to accept the discrimination; we have to accept the mandatory minimums, with the exception for the middle class white kids. We should not be forced to accept ineffective counterproductive mandatory minimums and religious discrimination as a price for good child health care, and that is why I oppose this rule. Mr. FROST. Mr. Speaker, I yield 2 minutes to the gentleman from New Jersey (Mr. Pascrell). (Mr. PASCRELL asked and was given permission to revise and extend his remarks.) Mr. PASCRELL. Mr. Speaker, I thank the gentleman from Texas for yielding me this time. Mr. Speaker, I am thrilled that the Children's Health Act of 2000 is on the floor today. I would like to thank the Chair of the Subcommittee on Health and the Environment, the gentleman from Florida (Mr. Bilirakis), and the ranking member, the gentleman from Ohio (Mr. Brown), for their leadership and determination to see the bill through. But I want to take special time to salute the gentleman from Pennsylvania (Mr. Greenwood) for his work on behalf of children in America. The gentleman from Pennsylvania has worked tirelessly on behalf of millions of Americans suffering from traumatic brain injury. He has also assisted in my efforts to create the first national traumatic brain injury registry, which is critical. I first became involved with this issue several years ago when a constituent of mine, Dennis Benigno, approached me to tell me about his son, who was struck by a car, hospitalized for months, leaving him with severe cognitive and physical damage. {time} 1045 As a result of his son's accident, Mr. Benigno has been on the front lines researching the disease, informing others, reaching out to the medical research and scientific community, and lobbying elected officials like myself. I am proud of the efforts and the progress my good friend has made on [[Page H8209]] behalf of traumatic brain injury, and I am pleased that the national registry will be included in the Children's Health Act. These brain injury registries will also charge hospitals and local and State departments of health with the task of collecting data for up to a year following the injury. A national registry will help all of us to better understand the injury, what types of treatment people have received, what services they use, and how we can best link people with services. I also hope that we fight each day, like Dennis does, to raise awareness of this disease and to fight for the injured, like his son. I urge all my colleagues to, when the bill comes up after we debate the rule, vote for the passage of this bill. Ms. PRYCE of Ohio. Mr. Speaker, I reserve the balance of my time. Mr. FROST. Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, as I indicated in my opening remarks, this is a good bill. The gentleman from Virginia (Mr. Scott) has some legitimate concerns about a particular matter that he was not able to address. The overall bill is an important piece of legislation. We have concerns on this side that we seem to be treading water here in not being able to bring anything up on the floor on a regular basis. We do not know from day to day what is going to be considered. This bill could have been done on suspension yesterday. That does not diminish the bill. This is an important piece of legislation. I support the bill and support the rule. Mr. Speaker, I yield back the balance of my time. Ms. PRYCE of Ohio. Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, in closing, let me just respond. This very well could have been considered under the suspension calendar last night. We would all have been considering this bill at about 11 p.m. if that were the case. Instead, we chose to come back in the light of day and with everyone well rested and alert and consider this important piece of legislation and allow the American public to hear all the goods things that we are promoting and adopting. In closing, let me remind my colleagues that the House has already passed this with a strong bipartisan support vote of 419-2. Our work today will allow us to dedicate important resources and focus Members on the very unique needs in the health and well-being of our children. I urge adoption of this straightforward, noncontroversial rule and passage of the comprehensive legislation. I applaud my colleagues, the gentleman from Florida (Chairman Bilirakis), and my colleague, the gentleman from Ohio (Mr. Brown), on their hard work. Mr. Speaker, I yield back the balance of my time, and I move the previous question on the resolution. The previous question was ordered. The resolution was agreed to. A motion to reconsider was laid on the table. Mr. BILIRAKIS. Mr. Speaker, pursuant to House Resolution 594, I call up from the Speaker's table the bill (H.R. 4365) to amend the Public Health Service Act with respect to children's health, with the Senate amendment thereto, and ask for its immediate consideration. The Clerk read the title of the bill. Motion Offered by Mr. Bilirakis Mr. BILIRAKIS. Mr. Speaker, I offer a motion. The SPEAKER pro tempore (Mr. Ose). The Clerk will designate the motion. The text of the motion is as follows: Mr. Bilirakis moves that the House concur in the Senate amendment to H.R. 4365, as follows: Senate amendment: Strike out all after the enacting clause and insert: SECTION 1. SHORT TITLE. This Act may be cited as the ``Children's Health Act of 2000''. SEC. 2. TABLE OF CONTENTS. The table of contents for this Act is as follows: Sec. 1. Short title. Sec. 2. Table of contents. DIVISION A--CHILDREN'S HEALTH TITLE I--AUTISM Sec. 101. Expansion, intensification, and coordination of activities of National Institutes of Health with respect to research on autism. Sec. 102. Developmental disabilities surveillance and research programs. Sec. 103. Information and education. Sec. 104. Inter-agency Autism Coordinating Committee. Sec. 105. Report to Congress. TITLE II--RESEARCH AND DEVELOPMENT REGARDING FRAGILE X Sec. 201. National Institute of Child Health and Human Development; research on fragile X. TITLE III--JUVENILE ARTHRITIS AND RELATED CONDITIONS Sec. 301. National Institute of Arthritis and Musculoskeletal and Skin Diseases; research on juvenile arthritis and related conditions. Sec. 302. Information clearinghouse. TITLE IV--REDUCING BURDEN OF DIABETES AMONG CHILDREN AND YOUTH Sec. 401. Programs of Centers for Disease Control and Prevention. Sec. 402. Programs of National Institutes of Health. TITLE V--ASTHMA SERVICES FOR CHILDREN Subtitle A--Asthma Services Sec. 501. Grants for children's asthma relief. Sec. 502. Technical and conforming amendments. Subtitle B--Prevention Activities Sec. 511. Preventive health and health services block grant; systems for reducing asthma-related illnesses through integrated pest management. Subtitle C--Coordination of Federal Activities Sec. 521. Coordination through National Institutes of Health. Subtitle D--Compilation of Data Sec. 531. Compilation of data by Centers for Disease Control and Prevention. TITLE VI--BIRTH DEFECTS PREVENTION ACTIVITIES Subtitle A--Folic Acid Promotion Sec. 601. Program regarding effects of folic acid in prevention of birth defects. Subtitle B--National Center on Birth Defects and Developmental Disabilities Sec. 611. National Center on Birth Defects and Developmental Disabilities. TITLE VII--EARLY DETECTION, DIAGNOSIS, AND TREATMENT REGARDING HEARING LOSS IN INFANTS Sec. 701. Purposes. Sec. 702. Programs of Health Resources and Services Administration, Centers for Disease Control and Prevention, and National Institutes of Health. TITLE VIII--CHILDREN AND EPILEPSY Sec. 801. National public health campaign on epilepsy; seizure disorder demonstration projects in medically underserved areas. TITLE IX--SAFE MOTHERHOOD; INFANT HEALTH PROMOTION Subtitle A--Safe Motherhood Prevention Research Sec. 901. Prevention research and other activities. Subtitle B--Pregnant Women and Infants Health Promotion Sec. 911. Programs regarding prenatal and postnatal health. TITLE X--PEDIATRIC RESEARCH INITIATIVE Sec. 1001. Establishment of pediatric research initiative. Sec. 1002. Investment in tomorrow's pediatric researchers. Sec. 1003. Review of regulations. Sec. 1004. Long-term child development study. TITLE XI--CHILDHOOD MALIGNANCIES Sec. 1101. Programs of Centers for Disease Control and Prevention and National Institutes of Health. TITLE XII--ADOPTION AWARENESS Subtitle A--Infant Adoption Awareness Sec. 1201. Grants regarding infant adoption awareness. Subtitle B--Special Needs Adoption Awareness Sec. 1211. Special needs adoption programs; public awareness campaign and other activities. TITLE XIII--TRAUMATIC BRAIN INJURY Sec. 1301. Programs of Centers for Disease Control and Prevention. Sec. 1302. Study and monitor incidence and prevalence. Sec. 1303. Programs of National Institutes of Health. Sec. 1304. Programs of Health Resources and Services Administration. Sec. 1305. State grants for protection and advocacy services. Sec. 1306. Authorization of appropriations for certain programs. TITLE XIV--CHILD CARE SAFETY AND HEALTH GRANTS Sec. 1401. Definitions. Sec. 1402. Authorization of appropriations. Sec. 1403. Programs. Sec. 1404. Amounts reserved; allotments. Sec. 1405. State applications. Sec. 1406. Use of funds. Sec. 1407. Reports. TITLE XV--HEALTHY START INITIATIVE Sec. 1501. Continuation of healthy start program. [[Page H8210]] TITLE XVI--ORAL HEALTH PROMOTION AND DISEASE PREVENTION Sec. 1601. Identification of interventions that reduce the burden and transmission of oral, dental, and craniofacial diseases in high risk populations; development of approaches for pediatric oral and craniofacial assessment. Sec. 1602. Oral health promotion and disease prevention. Sec. 1603. Coordinated program to improve pediatric oral health. TITLE XVII--VACCINE-RELATED PROGRAMS Subtitle A--Vaccine Compensation Program Sec. 1701. Content of petitions. Subtitle B-- Childhood Immunizations Sec. 1711. Childhood immunizations. TITLE XVIII--HEPATITIS C Sec. 1801. Surveillance and education regarding hepatitis C. TITLE XIX--NIH INITIATIVE ON AUTOIMMUNE DISEASES Sec. 1901. Autoimmune diseases; initiative through Director of National Institutes of Health. TITLE XX--GRADUATE MEDICAL EDUCATION PROGRAMS IN CHILDREN'S HOSPITALS Sec. 2001. Provisions to revise and extend program. TITLE XXI--SPECIAL NEEDS OF CHILDREN REGARDING ORGAN TRANSPLANTATION Sec. 2101. Organ Procurement and Transplantation Network; amendments regarding needs of children. TITLE XXII--MUSCULAR DYSTROPHY RESEARCH Sec. 2201. Muscular dystrophy research. TITLE XXIII--CHILDREN AND TOURETTE SYNDROME AWARENESS Sec. 2301. Grants regarding Tourette Syndrome. TITLE XXIV--CHILDHOOD OBESITY PREVENTION Sec. 2401. Programs operated through the Centers for Disease Control and Prevention. TITLE XXV--EARLY DETECTION AND TREATMENT REGARDING CHILDHOOD LEAD POISONING Sec. 2501. Centers for Disease Control and Prevention efforts to combat childhood lead poisoning. Sec. 2502. Grants for lead poisoning related activities. Sec. 2503. Training and reports by the Health Resources and Services Administration. Sec. 2504. Screenings, referrals, and education regarding lead poisoning. TITLE XXVI--SCREENING FOR HERITABLE DISORDERS Sec. 2601. Program to improve the ability of States to provide newborn and child screening for heritable disorders. TITLE XXVII--PEDIATRIC RESEARCH PROTECTIONS Sec. 2701. Requirement for additional protections for children involved in research. TITLE XXVIII--MISCELLANEOUS PROVISIONS Sec. 2801. Report regarding research on rare diseases in children. Sec. 2802. Study on metabolic disorders. TITLE XXIX--EFFECTIVE DATE Sec. 2901. Effective date. DIVISION B--YOUTH DRUG AND MENTAL HEALTH SERVICES Sec. 3001. Short title. TITLE XXXI--PROVISIONS RELATING TO SERVICES FOR CHILDREN AND ADOLESCENTS Sec. 3101. Children and violence. Sec. 3102. Emergency response. Sec. 3103. High risk youth reauthorization. Sec. 3104. Substance abuse treatment services for children and adolescents. Sec. 3105. Comprehensive community services for children with serious emotional disturbance. Sec. 3106. Services for children of substance abusers. Sec. 3107. Services for youth offenders. Sec. 3108. Grants for strengthening families through community partnerships. Sec. 3109. Programs to reduce underage drinking. Sec. 3110. Services for individuals with fetal alcohol syndrome. Sec. 3111. Suicide prevention. Sec. 3112. General provisions. TITLE XXXII--PROVISIONS RELATING TO MENTAL HEALTH Sec. 3201. Priority mental health needs of regional and national significance. Sec. 3202. Grants for the benefit of homeless individuals. Sec. 3203. Projects for assistance in transition from homelessness. Sec. 3204. Community mental health services performance partnership block grant. Sec. 3205. Determination of allotment. Sec. 3206. Protection and Advocacy for Mentally Ill Individuals Act of 1986. Sec. 3207. Requirement relating to the rights of residents of certain facilities. Sec. 3208. Requirement relating to the rights of residents of certain non-medical, community-based facilities for children and youth. Sec. 3209. Emergency mental health centers. Sec. 3210. Grants for jail diversion programs. Sec. 3211. Improving outcomes for children and adolescents through services integration between child welfare and mental health services. Sec. 3212. Grants for the integrated treatment of serious mental illness and co-occurring substance abuse. Sec. 3213. Training grants. TITLE XXXIII--PROVISIONS RELATING TO SUBSTANCE ABUSE Sec. 3301. Priority substance abuse treatment needs of regional and national significance. Sec. 3302. Priority substance abuse prevention needs of regional and national significance. Sec. 3303. Substance abuse prevention and treatment performance partnership block grant. Sec. 3304. Determination of allotments. Sec. 3305. Nondiscrimination and institutional safeguards for religious providers. Sec. 3306. Alcohol and drug prevention or treatment services for Indians and Native Alaskans. Sec. 3307. Establishment of commission. TITLE XXXIV--PROVISIONS RELATING TO FLEXIBILITY AND ACCOUNTABILITY Sec. 3401. General authorities and peer review. Sec. 3402. Advisory councils. Sec. 3403. General provisions for the performance partnership block grants. Sec. 3404. Data infrastructure projects. Sec. 3405. Repeal of obsolete addict referral provisions. Sec. 3406. Individuals with co-occurring disorders. Sec. 3407. Services for individuals with co-occurring disorders. TITLE XXXV--WAIVER AUTHORITY FOR PHYSICIANS WHO DISPENSE OR PRESCRIBE CERTAIN NARCOTIC DRUGS FOR MAINTENANCE TREATMENT OR DETOXIFICATION TREATMENT Sec. 3501. Short title. Sec. 3502. Amendment to Controlled Substances Act. TITLE XXXVI--METHAMPHETAMINE AND OTHER CONTROLLED SUBSTANCES Sec. 3601. Short title. Subtitle A--Methamphetamine Production, Trafficking, and Abuse Part I--Criminal Penalties Sec. 3611. Enhanced punishment of amphetamine laboratory operators. Sec. 3612. Enhanced punishment of amphetamine or methamphetamine laboratory operators. Sec. 3613. Mandatory restitution for violations of Controlled Substances Act and Controlled Substances Import and Export Act relating to amphetamine and methamphetamine. Sec. 3614. Methamphetamine paraphernalia. Part II--Enhanced Law Enforcement Sec. 3621. Environmental hazards associated with illegal manufacture of amphetamine and methamphetamine. Sec. 3622. Reduction in retail sales transaction threshold for non-safe harbor products containing pseudoephedrine or phenylpropanolamine. Sec. 3623. Training for Drug Enforcement Administration and State and local law enforcement personnel relating to clandestine laboratories. Sec. 3624. Combating methamphetamine and amphetamine in high intensity drug trafficking areas. Sec. 3625. Combating amphetamine and methamphetamine manufacturing and trafficking. Part III--Abuse Prevention and Treatment Sec. 3631. Expansion of methamphetamine research. Sec. 3632. Methamphetamine and amphetamine treatment initiative by Center for Substance Abuse Treatment. Sec. 3633. Study of methamphetamine treatment. Part IV--Reports Sec. 3641. Reports on consumption of methamphetamine and other illicit drugs in rural areas, metropolitan areas, and consolidated metropolitan areas. Sec. 3642. Report on diversion of ordinary, over-the-counter pseudoephedrine and phenylpropanolamine products. Subtitle B--Controlled Substances Generally Sec. 3651. Enhanced punishment for trafficking in list I chemicals. Sec. 3652. Mail order requirements. Sec. 3653. Theft and transportation of anhydrous ammonia for purposes of illicit production of controlled substances. Subtitle C--Ecstasy Anti-Proliferation Act of 2000 Sec. 3661. Short title. Sec. 3662. Findings. Sec. 3663. Enhanced punishment of Ecstasy traffickers. Sec. 3664. Emergency authority to United States Sentencing Commission. Sec. 3665. Expansion of Ecstasy and club drugs abuse prevention efforts. Subtitle D--Miscellaneous Sec. 3671. Antidrug messages on Federal Government Internet websites. Sec. 3672. Reimbursement by Drug Enforcement Administration of expenses incurred to remediate methamphetamine laboratories. Sec. 3673. Severability. [[Page H8211]] DIVISION A--CHILDREN'S HEALTH TITLE I--AUTISM SEC. 101. EXPANSION, INTENSIFICATION, AND COORDINATION OF ACTIVITIES OF NATIONAL INSTITUTES OF HEALTH WITH RESPECT TO RESEARCH ON AUTISM. Part B of title IV of the Public Health Service Act (42 U.S.C. 284 et seq.) is amended by adding at the end the following section: ``expansion, intensification, and coordination of activities of national institutes of health with respect to research on autism ``Sec. 409C. (a) In General.-- ``(1) Expansion of activities.--The Director of NIH (in this section referred to as the `Director') shall expand, intensify, and coordinate the activities of the National Institutes of Health with respect to research on autism. ``(2) Administration of program; collaboration among agencies.--The Director shall carry out this section acting through the Director of the National Institute of Mental Health and in collaboration with any other agencies that the Director determines appropriate. ``(b) Centers of Excellence.-- ``(1) In general.--The Director shall under subsection (a)(1) make awards of grants and contracts to public or nonprofit private entities to pay all or part of the cost of planning, establishing, improving, and providing basic operating support for centers of excellence regarding research on autism. ``(2) Research.--Each center under paragraph (1) shall conduct basic and clinical research into autism. Such research should include investigations into the cause, diagnosis, early detection, prevention, control, and treatment of autism. The centers, as a group, shall conduct research including the fields of developmental neurobiology, genetics, and psychopharmacology. ``(3) Services for patients.-- ``(A) In general.--A center under paragraph (1) may expend amounts provided under such paragraph to carry out a program to make individuals aware of opportunities to participate as subjects in research conducted by the centers. ``(B) Referrals and costs.--A program under subparagraph (A) may, in accordance with such criteria as the Director may establish, provide to the subjects described in such subparagraph, referrals for health and other services, and such patient care costs as are required for research. ``(C) Availability and access.--The extent to which a center can demonstrate availability and access to clinical services shall be considered by the Director in decisions about awarding grants to applicants which meet the scientific criteria for funding under this section. ``(4) Coordination of centers; reports.--The Director shall, as appropriate, provide for the coordination of information among centers under paragraph (1) and ensure regular communication between such centers, and may require the periodic preparation of reports on the activities of the centers and the submission of the reports to the Director. ``(5) Organization of centers.--Each center under paragraph (1) shall use the facilities of a single institution, or be formed from a consortium of cooperating institutions, meeting such requirements as may be prescribed by the Director. ``(6) Number of centers; duration of support.-- ``(A) In general.--The Director shall provide for the establishment of not less than 5 centers under paragraph (1). ``(B) Duration.--Support for a center established under paragraph (1) may be provided under this section for a period of not to exceed 5 years. Such period may be extended for 1 or more additional periods not exceeding 5 years if the operations of such center have been reviewed by an appropriate technical and scientific peer review group established by the Director and if such group has recommended to the Director that such period should be extended. ``(c) Facilitation of Research.--The Director shall under subsection (a)(1) provide for a program under which samples of tissues and genetic materials that are of use in research on autism are donated, collected, preserved, and made available for such research. The program shall be carried out in accordance with accepted scientific and medical standards for the donation, collection, and preservation of such samples. ``(d) Public Input.--The Director shall under subsection (a)(1) provide for means through which the public can obtain information on the existing and planned programs and activities of the National Institutes of Health with respect to autism and through which the Director can receive comments from the public regarding such programs and activities. ``(e) Funding.--There are authorized to be appropriated such sums as may be necessary to carry out this section. Amounts appropriated under this subsection are in addition to any other amounts appropriated for such purpose.''. SEC. 102. DEVELOPMENTAL DISABILITIES SURVEILLANCE AND RESEARCH PROGRAMS. (a) National Autism and Pervasive Developmental Disabilities Surveillance Program.-- (1) In general.--The Secretary of Health and Human Services (in this section referred to as the ``Secretary''), acting through the Director of the Centers for Disease Control and Prevention, may make awards of grants and cooperative agreements for the collection, analysis, and reporting of data on autism and pervasive developmental disabilities. In making such awards, the Secretary may provide direct technical assistance in lieu of cash. (2) Eligibility.--To be eligible to receive an award under paragraph (1) an entity shall be a public or nonprofit private entity (including health departments of States and political subdivisions of States, and including universities and other educational entities). (b) Centers of Excellence in Autism and Pervasive Developmental Disabilities Epidemiology.-- (1) In general.--The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall establish not less than 3 regional centers of excellence in autism and pervasive developmental disabilities epidemiology for the purpose of collecting and analyzing information on the number, incidence, correlates, and causes of autism and related developmental disabilities. (2) Recipients of awards for establishment of centers.-- Centers under paragraph (1) shall be established and operated through the awarding of grants or cooperative agreements to public or nonprofit private entities that conduct research, including health departments of States and political subdivisions of States, and including universities and other educational entities. (3) Certain requirements.--An award for a center under paragraph (1) may be made only if the entity involved submits to the Secretary an application containing such agreements and information as the Secretary may require, including an agreement that the center involved will operate in accordance with the following: (A) The center will collect, analyze, and report autism and pervasive developmental disabilities data according to guidelines prescribed by the Director, after consultation with relevant State and local public health officials, private sector developmental disability researchers, and advocates for those with developmental disabilities. (B) The center will assist with the development and coordination of State autism and pervasive developmental disabilities surveillance efforts within a region. (C) The center will identify eligible cases and controls through its surveillance systems and conduct research into factors which may cause autism and related developmental disabilities. (D) The center will develop or extend an area of special research expertise (including genetics, environmental exposure to contaminants, immunology, and other relevant research specialty areas). (c) Clearinghouse.--The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall carry out the following: (1) The Secretary shall establish a clearinghouse within the Centers for Disease Control and Prevention for the collection and storage of data generated from the monitoring programs established by this title. Through the clearinghouse, such Centers shall serve as the coordinating agency for autism and pervasive developmental disabilities surveillance activities. The functions of such a clearinghouse shall include facilitating the coordination of research and policy development relating to the epidemiology of autism and other pervasive developmental disabilities. (2) The Secretary shall coordinate the Federal response to requests for assistance from State health department officials regarding potential or alleged autism or developmental disability clusters. (d) Definition.--In this title, the term ``State'' means each of the several States, the District of Columbia, the Commonwealth of Puerto Rico, American Samoa, Guam, the Commonwealth of the Northern Mariana Islands, the Virgin Islands, and the Trust Territory of the Pacific Islands. (e) Authorization of Appropriations.--There are authorized to be appropriated such sums as may be necessary to carry out this section. SEC. 103. INFORMATION AND EDUCATION. (a) In General.--The Secretary shall establish and implement a program to provide information and education on autism to health professionals and the general public, including information and education on advances in the diagnosis and treatment of autism and training and continuing education through programs for scientists, physicians, and other health professionals who provide care for patients with autism. (b) Stipends.--The Secretary may use amounts made available under this section to provide stipends for health professionals who are enrolled in training programs under this section. (c) Authorization of Appropriations.--There are authorized to be appropriated such sums as may be necessary to carry out this section. SEC. 104. INTER-AGENCY AUTISM COORDINATING COMMITTEE. (a) Establishment.--The Secretary shall establish a committee to be known as the ``Autism Coordinating Committee'' (in this section referred to as the ``Committee'') to coordinate all efforts within the Department of Health and Human Services concerning autism, including activities carried out through the National Institutes of Health and the Centers for Disease Control and Prevention under this title (and the amendment made by this title). (b) Membership.-- (1) In general.--The Committee shall be composed of the Directors of such national research institutes, of the Centers for Disease Control and Prevention, and of such other agencies and such other officials as the Secretary determines appropriate. (2) Additional members.--If determined appropriate by the Secretary, the Secretary may appoint to the Committee-- (A) parents or legal guardians of individuals with autism or other pervasive developmental disorders; and [[Page H8212]] (B) representatives of other governmental agencies that serve children with autism such as the Department of Education. (c) Administrative Support; Terms of Service; Other Provisions.--The following shall apply with respect to the Committee: (1) The Committee shall receive necessary and appropriate administrative support from the Department of Health and Human Services. (2) Members of the Committee appointed under subsection (b)(2)(A) shall serve for a term of 3 years, and may serve for an unlimited number of terms if reappointed. (3) The Committee shall meet not less than 2 times each year. SEC. 105. REPORT TO CONGRESS. Not later than January 1, 2001, and each January 1 thereafter, the Secretary shall prepare and submit to the appropriate committees of Congress, a report concerning the implementation of this title and the amendments made by this title. TITLE II--RESEARCH AND DEVELOPMENT REGARDING FRAGILE X SEC. 201. NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT; RESEARCH ON FRAGILE X. Subpart 7 of part C of title IV of the Public Health Service Act is amended by adding at the end the following section: ``fragile x ``Sec. 452E. (a) Expansion and Coordination of Research Activities.--The Director of the Institute, after consultation with the advisory council for the Institute, shall expand, intensify, and coordinate the activities of the Institute with respect to research on the disease known as fragile X. ``(b) Research Centers.-- ``(1) In general.--The Director of the Institute shall make grants or enter into contracts for the development and operation of centers to conduct research for the purposes of improving the diagnosis and treatment of, and finding the cure for, fragile X. ``(2) Number of centers.-- ``(A) In general.--In carrying out paragraph (1), the Director of the Institute shall, to the extent that amounts are appropriated, and subject to subparagraph (B), provide for the establishment of at least three fragile X research centers. ``(B) Peer review requirement.--The Director of the Institute shall make a grant to, or enter into a contract with, an entity for purposes of establishing a center under paragraph (1) only if the grant or contract has been recommended after technical and scientific peer review required by regulations under section 492. ``(3) Activities.--The Director of the Institute, with the assistance of centers established under paragraph (1), shall conduct and support basic and biomedical research into the detection and treatment of fragile X. ``(4) Coordination among centers.--The Director of the Institute shall, as appropriate, provide for the coordination of the activities of the centers assisted under this section, including providing for the exchange of information among the centers. ``(5) Certain administrative requirements.--Each center assisted under paragraph (1) shall use the facilities of a single institution, or be formed from a consortium of cooperating institutions, meeting such requirements as may be prescribed by the Director of the Institute. ``(6) Duration of support.--Support may be provided to a center under paragraph (1) for a period not exceeding 5 years. Such period may be extended for one or more additional periods, each of which may not exceed 5 years, if the operations of such center have been reviewed by an appropriate technical and scientific peer review group established by the Director and if such group has recommended to the Director that such period be extended. ``(7) Authorization of appropriations.--For the purpose of carrying out this subsection, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2001 through 2005.''. TITLE III--JUVENILE ARTHRITIS AND RELATED CONDITIONS SEC. 301. NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES; RESEARCH ON JUVENILE ARTHRITIS AND RELATED CONDITIONS. (a) In General.--Subpart 4 of part C of title IV of the Public Health Service Act (42 U.S.C. 285d et seq.) is amended by inserting after section 442 the following section: ``juvenile arthritis and related conditions ``Sec. 442A. (a) Expansion and Coordination of Activities.--The Director of the Institute, in coordination with the Director of the National Institute of Allergy and Infectious Diseases, shall expand and intensify the programs of such Institutes with respect to research and related activities concerning juvenile arthritis and related conditions. ``(b) Coordination.--The Directors referred to in subsection (a) shall jointly coordinate the programs referred to in such subsection and consult with the Arthritis and Musculoskeletal Diseases Interagency Coordinating Committee. ``(c) Authorization of Appropriations.--For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2001 through 2005.''. (b) Pediatric Rheumatology.--Subpart 1 of part E of title VII of the Public Health Service Act (42 U.S.C. 294n et seq.) is amended by adding at the end the following: ``SEC. 763. PEDIATRIC RHEUMATOLOGY. ``(a) In General.--The Secretary, acting through the appropriate agencies, shall evaluate whether the number of pediatric rheumatologists is sufficient to address the health care needs of children with arthritis and related conditions, and if the Secretary determines that the number is not sufficient, shall develop strategies to help address the shortfall. ``(b) Report to Congress.--Not later than October 1, 2001, the Secretary shall submit to the Congress a report describing the results of the evaluation under subsection (a), and as applicable, the strategies developed under such subsection. ``(c) Authorization of Appropriations.--For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2001 through 2005.''. SEC. 302. INFORMATION CLEARINGHOUSE. Section 438(b) of the Public Health Service Act (42 U.S.C. 285d-3(b)) is amended by inserting ``, including juvenile arthritis and related conditions,'' after ``diseases''. TITLE IV--REDUCING BURDEN OF DIABETES AMONG CHILDREN AND YOUTH SEC. 401. PROGRAMS OF CENTERS FOR DISEASE CONTROL AND PREVENTION. Part B of title III of the Public Health Service Act (42 U.S.C. 243 et seq.) is amended by inserting after section 317G the following section: ``diabetes in children and youth ``Sec. 317H. (a) Surveillance on Juvenile Diabetes.--The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall develop a sentinel system to collect data on juvenile diabetes, including with respect to incidence and prevalence, and shall establish a national database for such data. ``(b) Type 2 Diabetes in Youth.--The Secretary shall implement a national public health effort to address type 2 diabetes in youth, including-- ``(1) enhancing surveillance systems and expanding research to better assess the prevalence and incidence of type 2 diabetes in youth and determine the extent to which type 2 diabetes is incorrectly diagnosed as type 1 diabetes among children; and ``(2) developing and improving laboratory methods to assist in diagnosis, treatment, and prevention of diabetes including, but not limited to, developing noninvasive ways to monitor blood glucose to prevent hypoglycemia and improving existing glucometers that measure blood glucose. ``(c) Authorization of Appropriations.--For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2001 through 2005.''. SEC. 402. PROGRAMS OF NATIONAL INSTITUTES OF HEALTH. Subpart 3 of part C of title IV of the Public Health Service Act (42 U.S.C. 285c et seq.) is amended by inserting after section 434 the following section: ``juvenile diabetes ``Sec. 434A. (a) Long-Term Epidemiology Studies.--The Director of the Institute shall conduct or support long-term epidemiology studies in which individuals with or at risk for type 1, or juvenile, diabetes are followed for 10 years or more. Such studies shall investigate the causes and characteristics of the disease and its complications. ``(b) Clinical Trial Infrastructure/Innovative Treatments for Juvenile Diabetes.--The Secretary, acting through the Director of the National Institutes of Health, shall support regional clinical research centers for the prevention, detection, treatment, and cure of juvenile diabetes. ``(c) Prevention of Type 1 Diabetes.--The Secretary, acting through the appropriate agencies, shall provide for a national effort to prevent type 1 diabetes. Such effort shall provide for a combination of increased efforts in research and development of prevention strategies, including consideration of vaccine development, coupled with appropriate ability to test the effectiveness of such strategies in large clinical trials of children and young adults. ``(d) Authorization of Appropriations.--For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2001 through 2005.''. TITLE V--ASTHMA SERVICES FOR CHILDREN Subtitle A--Asthma Services SEC. 501. GRANTS FOR CHILDREN'S ASTHMA RELIEF. Title III of the Public Health Service Act (42 U.S.C. 241 et seq.) is amended by adding at the end the following part: ``PART P--ADDITIONAL PROGRAMS ``SEC. 399L. CHILDREN'S ASTHMA TREATMENT GRANTS PROGRAM. ``(a) Authority To Make Grants.-- ``(1) In general.--In addition to any other payments made under this Act or title V of the Social Security Act, the Secretary shall award grants to eligible entities to carry out the following purposes: ``(A) To provide access to quality medical care for children who live in areas that have a high prevalence of asthma and who lack access to medical care. ``(B) To provide on-site education to parents, children, health care providers, and medical teams to recognize the signs and symptoms of asthma, and to train them in the use of medications to treat asthma and prevent its exacerbations. ``(C) To decrease preventable trips to the emergency room by making medication available to individuals who have not previously had access to treatment or education in the management of asthma. ``(D) To provide other services, such as smoking cessation programs, home modification, and other direct and support services that ameliorate conditions that exacerbate or induce asthma. ``(2) Certain projects.--In making grants under paragraph (1), the Secretary may make [[Page H8213]] grants designed to develop and expand the following projects: ``(A) Projects to provide comprehensive asthma services to children in accordance with the guidelines of the National Asthma Education and Prevention Program (through the National Heart, Lung and Blood Institute), including access to care and treatment for asthma in a community-based setting. ``(B) Projects to fully equip mobile health care clinics that provide preventive asthma care including diagnosis, physical examinations, pharmacological therapy, skin testing, peak flow meter testing, and other asthma-related health care services. ``(C) Projects to conduct validated asthma management education programs for patients with asthma and their families, including patient education regarding asthma management, family education on asthma management, and the distribution of materials, including displays and videos, to reinforce concepts presented by medical teams. ``(2) Award of grants.-- ``(A) Application.-- ``(i) In general.--An eligible entity shall submit an application to the Secretary for a grant under this section in such form and manner as the Secretary may require. ``(ii) Required information.--An application submitted under this subparagraph shall include a plan for the use of funds awarded under the grant and such other information as the Secretary may require. ``(B) Requirement.--In awarding grants under this section, the Secretary shall give preference to eligible entities that demonstrate that the activities to be carried out under this section shall be in localities within areas of known or suspected high prevalence of childhood asthma or high asthma- related mortality or high rate of hospitalization or emergency room visits for asthma (relative to the average asthma prevalence rates and associated mortality rates in the United States). Acceptable data sets to demonstrate a high prevalence of childhood asthma or high asthma-related mortality may include data from Federal, State, or local vital statistics, claims data under title XIX or XXI of the Social Security Act, other public health statistics or surveys, or other data that the Secretary, in consultation with the Director of the Centers for Disease Control and Prevention, deems appropriate. ``(3) Definition of eligible entity.--For purposes of this section, the term `eligible entity' means a public or nonprofit private entity (including a State or political subdivision of a State), or a consortium of any of such entities. ``(b) Coordination With Other Children's Programs.--An eligible entity shall identify in the plan submitted as part of an application for a grant under this section how the entity will coordinate operations and activities under the grant with-- ``(1) other programs operated in the State that serve children with asthma, including any such programs operated under titles V, XIX, or XXI of the Social Security Act; and ``(2) one or more of the following-- ``(A) the child welfare and foster care and adoption assistance programs under parts B and E of title IV of such Act; ``(B) the head start program established under the Head Start Act (42 U.S.C. 9831 et seq.); ``(C) the program of assistance under the special supplemental nutrition program for women, infants and children (WIC) under section 17 of the Child Nutrition Act of 1966 (42 U.S.C. 1786); ``(